{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":2548572,"items":[{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T04:55:24Z","timestamp":1695531324496},"posted":{"date-parts":[[2023,9,23]]},"reference-count":0,"publisher":"Polygence","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.58445\/rars.484","type":"posted-content","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:19:05Z","timestamp":1695500345000},"source":"Crossref","is-referenced-by-count":0,"title":["Gene therapy and gene editing in human disease: CRISPR and beyond"],"prefix":"10.58445","author":[{"given":"Sarah","family":"Sabin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37285","deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:19:06Z","timestamp":1695500346000},"score":25.531624,"resource":{"primary":{"URL":"https:\/\/research-archive.org\/index.php\/rars\/preprint\/view\/484\/version\/621"}},"issued":{"date-parts":[[2023,9,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.58445\/rars.484","published":{"date-parts":[[2023,9,23]]},"subtype":"preprint"},{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:33:53Z","timestamp":1743006833430,"version":"3.40.3"},"publisher-location":"Cham","reference-count":260,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030933326"},{"type":"electronic","value":"9783030933333"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-93333-3_5","type":"book-chapter","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:02:50Z","timestamp":1654178570000},"page":"85-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CRISPR-Cas-Based Gene Therapy to Target Viral Infections"],"prefix":"10.1007","author":[{"given":"Mouraya","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Herrera-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","volume":"93","author":"PI Andersen","year":"2020","unstructured":"Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjoras, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., et al. (2020). Discovery and development of safe-in-man broad-spectrum antiviral agents. International Journal of Infectious Diseases, 93, 268\u2013276.","journal-title":"International Journal of Infectious Diseases"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imr.12098","volume":"255","author":"BS Graham","year":"2013","unstructured":"Graham, B. S. (2013). Advances in antiviral vaccine development. Immunological Reviews, 255, 230\u2013242.","journal-title":"Immunological Reviews"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","volume":"46","author":"D Calina","year":"2020","unstructured":"Calina, D., Docea, A. O., Petrakis, D., Egorov, A. M., Ishmukhametov, A. A., Gabibov, A. G., Shtilman, M. I., Kostoff, R., Carvalho, F., Vinceti, M., et al. (2020). Towards effective COVID19 vaccines: Updates, perspectives and challenges (Review). International Journal of Molecular Medicine, 46, 3\u201316.","journal-title":"International Journal of Molecular Medicine"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq, E., & Li, G. (2016). Approved antiviral drugs over the past 50 years. Clinical Microbiology Reviews, 29, 695\u2013747.","journal-title":"Clinical Microbiology Reviews"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.virusres.2017.12.010","volume":"244","author":"DY Jin","year":"2018","unstructured":"Jin, D. Y., & Berkhout, B. (2018). CRISPR-Cas antiviral strategies. Virus Research, 244, 285.","journal-title":"Virus Research"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","volume":"169","author":"Y Ishino","year":"1987","unstructured":"Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987). Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169, 5429\u20135433.","journal-title":"Journal of Bacteriology"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","volume":"43","author":"R Jansen","year":"2002","unstructured":"Jansen, R., van Embden, J. D. A., Gaastra, W., & Schouls, L. M. (2002). Identification of genes that are associated with DNA repeats in prokaryotes. Molecular Microbiology, 43, 1565\u20131575.","journal-title":"Molecular Microbiology"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/535342a","volume":"535","author":"H Ledford","year":"2016","unstructured":"Ledford, H. (2016). The unsung heroes of CRISPR. Nature, 535, 342\u2013344.","journal-title":"Nature"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cell.2015.12.041","volume":"164","author":"ES Lander","year":"2016","unstructured":"Lander, E. S. (2016). The heroes of CRISPR. Cell, 164, 18\u201328.","journal-title":"Cell"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","volume":"60","author":"FJ Mojica","year":"2005","unstructured":"Mojica, F. J., Diez-Villasenor, C., Garcia-Martinez, J., & Soria, E. (2005). Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. Journal of Molecular Evolution, 60, 174\u2013182.","journal-title":"Journal of Molecular Evolution"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/mic.0.27437-0","volume":"151","author":"C Pourcel","year":"2005","unstructured":"Pourcel, C., Salvignol, G., & Vergnaud, G. (2005). CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology, 151, 653\u2013663.","journal-title":"Microbiology"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","volume":"151","author":"A Bolotin","year":"2005","unstructured":"Bolotin, A., Ouinquis, B., Sorokin, A., & Ehrlich, S. D. (2005). Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology-SGM, 151, 2551\u20132561.","journal-title":"Microbiology-SGM"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tibs.2009.05.002","volume":"34","author":"J van der Oost","year":"2009","unstructured":"van der Oost, J., Jore, M. M., Westra, E. R., Lundgren, M., & Brouns, S. J. (2009). CRISPR-based adaptive and heritable immunity in prokaryotes. Trends in Biochemical Sciences, 34, 401\u2013407.","journal-title":"Trends in Biochemical Sciences"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2017.02.004","volume":"37","author":"AG Patterson","year":"2017","unstructured":"Patterson, A. G., Yevstigneyeva, M. S., & Fineran, P. C. (2017). Regulation of CRISPR-Cas adaptive immune systems. Current Opinion in Microbiology, 37, 1\u20137.","journal-title":"Current Opinion in Microbiology"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature15386","volume":"526","author":"LA Marraffini","year":"2015","unstructured":"Marraffini, L. A. (2015). CRISPR-Cas immunity in prokaryotes. Nature, 526, 55\u201361.","journal-title":"Nature"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature09523","volume":"468","author":"JE Garneau","year":"2010","unstructured":"Garneau, J. E., Dupuis, M. E., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadan, A. H., & Moineau, S. (2010). The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67\u201371.","journal-title":"Nature"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816\u2013821.","journal-title":"Science"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 471, 602\u2013607.","journal-title":"Nature"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature13011","volume":"507","author":"SH Sternberg","year":"2014","unstructured":"Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014). DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 507, 62\u201367.","journal-title":"Nature"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013). RNA-guided human genome engineering via Cas9. Science, 339, 823\u2013826.","journal-title":"Science"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.2507","volume":"31","author":"SW Cho","year":"2013","unstructured":"Cho, S. W., Kim, S., Kim, J. M., & Kim, J. S. (2013). Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nature Biotechnology, 31, 230\u2013232.","journal-title":"Nature Biotechnology"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","volume":"168","author":"N Savic","year":"2016","unstructured":"Savic, N., & Schwank, G. (2016). Advances in therapeutic CRISPR\/Cas9 genome editing. Translational Research, 168, 15\u201321.","journal-title":"Translational Research"},{"key":"5_CR23","doi-asserted-by":"crossref","unstructured":"Bannikov, A. V., & Lavrov, A. V. (2017). [CRISPR\/CAS9, the King of Genome Editing Tools]. Molecular Biology (Mosk), 51, 582\u2013594. 2017\/09\/14 ed.","DOI":"10.1134\/S0026893317040033"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J., Charpentier, E., Haft, D. H., et al. (2015). An updated evolutionary classification of CRISPR-Cas systems. Nature Reviews. Microbiology, 13, 722\u2013736.","journal-title":"Nature Reviews. Microbiology"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"aad5147","DOI":"10.1126\/science.aad5147","volume":"353","author":"P Mohanraju","year":"2016","unstructured":"Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & van der Oost, J. (2016). Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science, 353, aad5147.","journal-title":"Science"},{"key":"5_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna, J. A., & Charpentier, E. (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 346, 1258096.","journal-title":"Science"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-2687-9_4","volume":"1311","author":"KS Makarova","year":"2015","unstructured":"Makarova, K. S., & Koonin, E. V. (2015). Annotation and classification of CRISPR-Cas Systems. Methods in Molecular Biology, 1311, 47\u201375.","journal-title":"Methods in Molecular Biology"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1093\/nar\/gku241","volume":"42","author":"K Chylinski","year":"2014","unstructured":"Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014). Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Research, 42, 6091\u20136105.","journal-title":"Nucleic Acids Research"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","volume":"46","author":"F Jiang","year":"2017","unstructured":"Jiang, F., & Doudna, J. A. (2017). CRISPR-Cas9 structures and mechanisms. Annual Review of Biophysics, 46, 505\u2013529.","journal-title":"Annual Review of Biophysics"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4161\/rna.24321","volume":"10","author":"K Chylinski","year":"2013","unstructured":"Chylinski, K., Le Rhun, A., & Charpentier, E. (2013). The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biology, 10, 726\u2013737.","journal-title":"RNA Biology"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2009.07.040","volume":"139","author":"CR Hale","year":"2009","unstructured":"Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009). RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell, 139, 945\u2013956.","journal-title":"Cell"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1109397109","volume":"109","author":"G Gasiunas","year":"2012","unstructured":"Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012). Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences of the United States of America, 109, E2579\u2013E2586.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","volume":"156","author":"H Nishimasu","year":"2014","unstructured":"Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014). Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 156, 935\u2013949.","journal-title":"Cell"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature13579","volume":"513","author":"C Anders","year":"2014","unstructured":"Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014). Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature, 513, 569\u2013573.","journal-title":"Nature"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology, 31, 827\u2013832.","journal-title":"Nature Biotechnology"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cr.2019.08.002","volume":"8","author":"L Tang","year":"2019","unstructured":"Tang, L., Yang, F., He, X., Xie, H., Liu, X., Fu, J., Xi, H., Lu, X., Liu, C., Song, Z., et al. (2019). Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells. Cell Regeneration, 8, 44\u201350.","journal-title":"Cell Regeneration"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","volume":"79","author":"MR Lieber","year":"2010","unstructured":"Lieber, M. R. (2010). The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annual Review of Biochemistry, 79, 181\u2013211.","journal-title":"Annual Review of Biochemistry"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","volume":"77","author":"J San Filippo","year":"2008","unstructured":"San Filippo, J., Sung, P., & Klein, H. (2008). Mechanism of eukaryotic homologous recombination. Annual Review of Biochemistry, 77, 229\u2013257.","journal-title":"Annual Review of Biochemistry"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 152, 1173\u20131183.","journal-title":"Cell"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nmeth.2600","volume":"10","author":"P Perez-Pinera","year":"2013","unstructured":"Perez-Pinera, P., Kocak, D. D., Vockley, C. M., Adler, A. F., Kabadi, A. M., Polstein, L. R., Thakore, P. I., Glass, K. A., Ousterout, D. G., Leong, K. W., et al. (2013). RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nature Methods, 10, 973\u2013976.","journal-title":"Nature Methods"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1093\/nar\/gkt520","volume":"41","author":"D Bikard","year":"2013","unstructured":"Bikard, D., Jiang, W. Y., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Research, 41, 7429\u20137437.","journal-title":"Nucleic Acids Research"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmeth.3312","volume":"12","author":"A Chavez","year":"2015","unstructured":"Chavez, A., Scheiman, J., Vora, S., Pruitt, B. W., Tuttle, M., Iyer, E. P. R., Lin, S. L., Kiani, S., Guzman, C. D., Wiegand, D. J., et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nature Methods, 12, 326\u2013U365.","journal-title":"Nature Methods"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature, 517, 583\u2013U332.","journal-title":"Nature"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","volume":"159","author":"ME Tanenbaum","year":"2014","unstructured":"Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S., & Vale, R. D. (2014). A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell, 159, 635\u2013646.","journal-title":"Cell"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 159, 647\u2013661.","journal-title":"Cell"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., & Qi, L. S. (2013). CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature Protocols, 8, 2180\u20132196.","journal-title":"Nature Protocols"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature12048","volume":"497","author":"TR Sampson","year":"2013","unstructured":"Sampson, T. R., Saroj, S. D., Llewellyn, A. C., Tzeng, Y. L., & Weiss, D. S. (2013). A CRISPR\/Cas system mediates bacterial innate immune evasion and virulence. Nature, 497, 254\u2013257.","journal-title":"Nature"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.1422340112","volume":"112","author":"AA Price","year":"2015","unstructured":"Price, A. A., Sampson, T. R., Ratner, H. K., Grakoui, A., & Weiss, D. S. (2015). Cas9-mediated targeting of viral RNA in eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America, 112, 6164\u20136169.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/s41467-017-01836-2","volume":"8","author":"MA Moreno-Mateos","year":"2017","unstructured":"Moreno-Mateos, M. A., Fernandez, J. P., Rouet, R., Vejnar, C. E., Lane, M. A., Mis, E., Khokha, M. K., Doudna, J. A., & Giraldez, A. J. (2017). CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing. Nature Communications, 8, 2024.","journal-title":"Nature Communications"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163, 759\u2013771.","journal-title":"Cell"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nbt.3620","volume":"34","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P., Tsai, S. Q., Prew, M. S., Nguyen, N. T., Welch, M. M., Lopez, J. M., McCaw, Z. R., Aryee, M. J., & Joung, J. K. (2016). Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nature Biotechnology, 34, 869\u2013874.","journal-title":"Nature Biotechnology"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41421-018-0069-3","volume":"4","author":"F Teng","year":"2018","unstructured":"Teng, F., Cui, T., Feng, G., Guo, L., Xu, K., Gao, Q., Li, T., Li, J., Zhou, Q., & Li, W. (2018). Repurposing CRISPR-Cas12b for mammalian genome engineering. Cell Discovery, 4, 63.","journal-title":"Cell Discovery"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41467-018-08224-4","volume":"10","author":"J Strecker","year":"2019","unstructured":"Strecker, J., Jones, S., Koopal, B., Schmid-Burgk, J., Zetsche, B., Gao, L., Makarova, K. S., Koonin, E. V., & Zhang, F. (2019). Engineering of CRISPR-Cas12b for human genome editing. Nature Communications, 10, 212.","journal-title":"Nature Communications"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1093\/nar\/gkaa208","volume":"48","author":"T Karvelis","year":"2020","unstructured":"Karvelis, T., Bigelyte, G., Young, J. K., Hou, Z., Zedaveinyte, R., Budre, K., Paulraj, S., Djukanovic, V., Gasior, S., Silanskas, A., et al. (2020). PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage. Nucleic Acids Research, 48, 5016\u20135023.","journal-title":"Nucleic Acids Research"},{"key":"5_CR55","doi-asserted-by":"publisher","unstructured":"Gao, Z., Fan, M., Das, A. T., Herrera-Carrillo, E., & Berkhout, B. (2020). Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA. Nucleic Acids Research. https:\/\/doi.org\/10.1093\/nar\/gkaa226","DOI":"10.1093\/nar\/gkaa226"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","volume":"358","author":"DBT Cox","year":"2017","unstructured":"Cox, D. B. T., Gootenberg, J. S., Abudayyeh, O. O., Franklin, B., Kellner, M. J., Joung, J., & Zhang, F. (2017). RNA editing with CRISPR-Cas13. Science, 358, 1019\u20131027.","journal-title":"Science"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature24049","volume":"550","author":"OO Abudayyeh","year":"2017","unstructured":"Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017). RNA targeting with CRISPR-Cas13. Nature, 550, 280\u2013284.","journal-title":"Nature"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cell.2018.09.001","volume":"175","author":"C Zhang","year":"2018","unstructured":"Zhang, C., Konermann, S., Brideau, N. J., Lotfy, P., Wu, X. B., Novick, S. J., Strutzenberg, T., Griffin, P. R., Hsu, P. D., & Lyumkis, D. (2018). Structural basis for the RNA-guided ribonuclease activity of CRISPR-Cas13d. Cell, 175, 212\u2013223.e17.","journal-title":"Cell"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13059-019-1881-2","volume":"20","author":"A Mahas","year":"2019","unstructured":"Mahas, A., Aman, R., & Mahfouz, M. (2019). CRISPR-Cas13d mediates robust RNA virus interference in plants. Genome Biology, 20, 263.","journal-title":"Genome Biology"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.celrep.2019.02.094","volume":"26","author":"IM Slaymaker","year":"2019","unstructured":"Slaymaker, I. M., Mesa, P., Kellner, M. J., Kannan, S., Brignole, E., Koob, J., Feliciano, P. R., Stella, S., Abudayyeh, O. O., Gootenberg, J. S., et al. (2019). High-resolution structure of Cas13b and biochemical characterization of RNA targeting and cleavage. Cell Reports, 26, 3741\u20133751 e3745.","journal-title":"Cell Reports"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41592-021-01124-4","volume":"18","author":"C Xu","year":"2021","unstructured":"Xu, C., Zhou, Y., Xiao, Q., He, B., Geng, G., Wang, Z., Cao, B., Dong, X., Bai, W., Wang, Y., et al. (2021). Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes. Nature Methods, 18, 499\u2013506.","journal-title":"Nature Methods"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","volume":"353","author":"OO Abudayyeh","year":"2016","unstructured":"Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 353, aaf5573.","journal-title":"Science"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature19802","volume":"538","author":"A East-Seletsky","year":"2016","unstructured":"East-Seletsky, A., O\u2019Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016). Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 538, 270\u2013273.","journal-title":"Nature"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.molcel.2016.12.023","volume":"65","author":"AA Smargon","year":"2017","unstructured":"Smargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K. J., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017). Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Molecular Cell, 65, 618\u2013630.e7.","journal-title":"Molecular Cell"},{"issue":"665\u2013676","key":"5_CR65","volume":"173","author":"S Konermann","year":"2018","unstructured":"Konermann, S., Lotfy, P., Brideau, N. J., Oki, J., Shokhirev, M. N., & Hsu, P. D. (2018). Transcriptome engineering with RNA-targeting Type VI-D CRISPR effectors. Cell, 173(665\u2013676), e614.","journal-title":"Cell"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aav4294","volume":"362","author":"LB Harrington","year":"2018","unstructured":"Harrington, L. B., Burstein, D., Chen, J. S., Paez-Espino, D., Ma, E., Witte, I. P., Cofsky, J. C., Kyrpides, N. C., Banfield, J. F., & Doudna, J. A. (2018). Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science, 362, 839\u2013842.","journal-title":"Science"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s00216-018-0873-5","volume":"410","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Wang, Q., Xu, X., Xia, Q., Long, F., Li, W., Shui, Y., Xia, X., & Wang, J. (2018). Detection of target DNA with a novel Cas9\/sgRNAs-associated reverse PCR (CARP) technique. Analytical and Bioanalytical Chemistry, 410, 2889\u20132900.","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","volume":"165","author":"K Pardee","year":"2016","unstructured":"Pardee, K., Green, A. A., Takahashi, M. K., Braff, D., Lambert, G., Lee, J. W., Ferrante, T., Ma, D., Donghia, N., Fan, M., et al. (2016). Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell, 165, 1255\u20131266.","journal-title":"Cell"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/acs.analchem.7b04542","volume":"90","author":"MQ Huang","year":"2018","unstructured":"Huang, M. Q., Zhou, X. M., Wang, H. Y., & Xing, D. (2018). Clustered regularly interspaced short palindromic repeats\/Cas9 triggered isothermal amplification for site-specific nucleic acid detection. Analytical Chemistry, 90, 2193\u20132200.","journal-title":"Analytical Chemistry"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13059-019-1742-z","volume":"20","author":"F Teng","year":"2019","unstructured":"Teng, F., Guo, L., Cui, T. T., Wang, X. G., Xu, K., Gao, Q. Q., Zhou, Q., & Li, W. (2019). CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity. Genome Biology, 20, 132.","journal-title":"Genome Biology"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aar6245","volume":"360","author":"JS Chen","year":"2018","unstructured":"Chen, J. S., Ma, E. B., Harrington, L. B., Da Costa, M., Tian, X. R., Palefsky, J. M., & Doudna, J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 360, 436\u2013439.","journal-title":"Science"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41422-018-0022-x","volume":"28","author":"SY Li","year":"2018","unstructured":"Li, S. Y., Cheng, Q. X., Liu, J. K., Nie, X. Q., Zhao, G. P., & Wang, J. (2018). CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Research, 28, 491\u2013493.","journal-title":"Cell Research"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","volume":"14","author":"MJ Kellner","year":"2019","unstructured":"Kellner, M. J., Koob, J. G., Gootenberg, J. S., Abudayyeh, O. O., & Zhang, F. (2019). SHERLOCK: Nucleic acid detection with CRISPR nucleases. Nature Protocols, 14, 2986\u20133012.","journal-title":"Nature Protocols"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.aam9321","volume":"356","author":"JS Gootenberg","year":"2017","unstructured":"Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017). Nucleic acid detection with CRISPR-Cas13a\/C2c2. Science, 356, 438\u2013442.","journal-title":"Science"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1126\/science.aas8836","volume":"360","author":"C Myhrvold","year":"2018","unstructured":"Myhrvold, C., Freije, C. A., Gootenberg, J. S., Abudayyeh, O. O., Metsky, H. C., Durbin, A. F., Kellner, M. J., Tan, A. L., Paul, L. M., Parham, L. A., et al. (2018). Field-deployable viral diagnostics using CRISPR-Cas13. Science, 360, 444\u2013448.","journal-title":"Science"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1166\/jbn.2019.2742","volume":"15","author":"YF Liu","year":"2019","unstructured":"Liu, Y. F., Xu, H. P., Liu, C., Peng, L. J., Khan, H., Cui, L. B., Huang, R., Wu, C., Shen, S. S., Wang, S., et al. (2019). CRISPR-Cas13a nanomachine based simple technology for avian influenza A (H7N9) virus on-site detection. Journal of Biomedical Nanotechnology, 15, 790\u2013798.","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1373\/clinchem.2018.299347","volume":"65","author":"YT Wu","year":"2019","unstructured":"Wu, Y. T., Liu, S. X., Wang, F., & Zeng, M. S. (2019). Room temperature detection of plasma epstein-barr virus DNA with CRISPR-Cas13. Clinical Chemistry, 65, 591\u2013592.","journal-title":"Clinical Chemistry"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1056\/NEJMc2026172","volume":"383","author":"J Joung","year":"2020","unstructured":"Joung, J., Ladha, A., Saito, M., Kim, N. G., Woolley, A. E., Segel, M., Barretto, R. P. J., Ranu, A., Macrae, R. K., Faure, G., et al. (2020). Detection of SARS-CoV-2 with SHERLOCK one-pot testing. New England Journal of Medicine, 383, 1492\u20131494.","journal-title":"New England Journal of Medicine"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"ofaa392","DOI":"10.1093\/ofid\/ofaa392","volume":"7","author":"E Normandin","year":"2020","unstructured":"Normandin, E., Solomon, I. H., Zamirpour, S., Lemieux, J., Freije, C. A., Mukerji, S. S., Tomkins-Tinch, C., Park, D., Sabeti, P. C., & Piantadosi, A. (2020). Powassan virus neuropathology and genomic diversity in patients with fatal encephalitis. Open Forum Infect Dis, 7, ofaa392.","journal-title":"Open Forum Infect Dis"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1038\/s41467-020-17994-9","volume":"11","author":"KG Barnes","year":"2020","unstructured":"Barnes, K. G., Lachenauer, A. E., Nitido, A., Siddiqui, S., Gross, R., Beitzel, B., Siddle, K. J., Freije, C. A., Dighero-Kemp, B., Mehta, S. B., et al. (2020). Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nature Communications, 11, 4131.","journal-title":"Nature Communications"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1080\/22221751.2020.1763857","volume":"9","author":"LA Curti","year":"2020","unstructured":"Curti, L. A., Pereyra-Bonnet, F., Repizo, G. D., Fay, J. V., Salvatierra, K., Blariza, M. J., Ibanez-Alegre, D., Rinflerch, A. R., Miretti, M., & Gimenez, C. A. (2020). CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease. Emerging Microbes and Infecection, 9, 1140\u20131148.","journal-title":"Emerging Microbes and Infecection"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","volume":"38","author":"JP Broughton","year":"2020","unstructured":"Broughton, J. P., Deng, X., Yu, G., Fasching, C. L., Servellita, V., Singh, J., Miao, X., Streithorst, J. A., Granados, A., Sotomayor-Gonzalez, A., et al. (2020). CRISPR-Cas12-based detection of SARS-CoV-2. Nature Biotechnology, 38, 870\u2013874.","journal-title":"Nature Biotechnology"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"198129","DOI":"10.1016\/j.virusres.2020.198129","volume":"288","author":"Z Ali","year":"2020","unstructured":"Ali, Z., Aman, R., Mahas, A., Rao, G. S., Tehseen, M., Marsic, T., Salunke, R., Subudhi, A. K., Hala, S. M., Hamdan, S. M., et al. (2020). iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Research, 288, 198129.","journal-title":"Virus Research"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2279-8","volume":"582","author":"CM Ackerman","year":"2020","unstructured":"Ackerman, C. M., Myhrvold, C., Thakku, S. G., Freije, C. A., Metsky, H. C., Yang, D. K., Ye, S. H., Boehm, C. K., Kosoko-Thoroddsen, T. S. F., Kehe, J., et al. (2020). Massively multiplexed nucleic acid detection with Cas13. Nature, 582, 277\u2013282.","journal-title":"Nature"},{"key":"5_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3703","volume":"7","author":"B Ning","year":"2021","unstructured":"Ning, B., Yu, T., Zhang, S. W., Huang, Z., Tian, D., Lin, Z., Niu, A., Golden, N., Hensley, K., Threeton, B., et al. (2021). A smartphone-read ultrasensitive and quantitative saliva test for COVID-19. Science Advances, 7, eabe3703.","journal-title":"Science Advances"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cell.2020.12.001","volume":"184","author":"P Fozouni","year":"2021","unstructured":"Fozouni, P., Son, S. M., Derby, M. D. D., Knott, G. J., Gray, C. N., D\u2019Ambrosio, M. V., Zhao, C. Y., Switz, N. A., Kumar, G. R., Stephens, S. I., et al. (2021). Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy. Cell, 184, 323\u2013333.e9.","journal-title":"Cell"},{"key":"5_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112642","volume":"169","author":"YJ Chen","year":"2020","unstructured":"Chen, Y. J., Shi, Y., Chen, Y., Yang, Z., Wu, H., Zhou, Z. H., Li, J., Ping, J. F., He, L. P., Shen, H., et al. (2020). Contamination-free visual detection of SARS-CoV-2 with CRISPR\/Cas12a: A promising method in the point-of-care detection. Biosensors & Bioelectronics, 169, 112642.","journal-title":"Biosensors & Bioelectronics"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1038\/s41467-020-19097-x","volume":"11","author":"J Arizti-Sanz","year":"2020","unstructured":"Arizti-Sanz, J., Freije, C. A., Stanton, A. C., Petros, B. A., Boehm, C. K., Siddiqui, S., Shaw, B. M., Adams, G., Kosoko-Thoroddsen, T. S. F., Kemball, M. E., et al. (2020). Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nature Communications, 11, 5921.","journal-title":"Nature Communications"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"29518","DOI":"10.1073\/pnas.2010254117","volume":"117","author":"A Ramachandran","year":"2020","unstructured":"Ramachandran, A., Huyke, D. A., Sharma, E., Sahoo, M. K., Huang, C., Banaei, N., Pinsky, B. A., & Santiago, J. G. (2020). Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America, 117, 29518\u201329525.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"112316","DOI":"10.1016\/j.bios.2020.112316","volume":"164","author":"Z Huang","year":"2020","unstructured":"Huang, Z., Tian, D., Liu, Y., Lin, Z., Lyon, C. J., Lai, W. H., Fusco, D., Drouin, A., Yin, X. M., Hu, T., et al. (2020). Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosensors & Bioelectronics, 164, 112316.","journal-title":"Biosensors & Bioelectronics"},{"key":"5_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008705","volume":"16","author":"TY Hou","year":"2020","unstructured":"Hou, T. Y., Zeng, W. Q., Yang, M. L., Chen, W. J., Ren, L. L., Ai, J. W., Wu, J., Liao, Y. L., Gou, X. J., Li, Y. J., et al. (2020). Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19. PLoS Pathogens, 16, e1008705.","journal-title":"PLoS Pathogens"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41551-020-00603-x","volume":"4","author":"M Patchsung","year":"2020","unstructured":"Patchsung, M., Jantarug, K., Pattama, A., Aphicho, K., Suraritdechachai, S., Meesawat, P., Sappakhaw, K., Leelahakorn, N., Ruenkam, T., Wongsatit, T., et al. (2020). Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nature Biomedical Engineering, 4, 1140\u20131149.","journal-title":"Nature Biomedical Engineering"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41421-020-0174-y","volume":"6","author":"L Guo","year":"2020","unstructured":"Guo, L., Sun, X., Wang, X., Liang, C., Jiang, H., Gao, Q., Dai, M., Qu, B., Fang, S., Mao, Y., et al. (2020). SARS-CoV-2 detection with CRISPR diagnostics. Cell Discovery, 6, 34.","journal-title":"Cell Discovery"},{"key":"5_CR94","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nano.2019.03.006","volume":"18","author":"G Aquino-Jarquin","year":"2019","unstructured":"Aquino-Jarquin, G. (2019). CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic. Nanomedicine: Nanotechnology, Biology and Medicine, 18, 428\u2013431.","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.tibtech.2019.03.015","volume":"37","author":"MZ Khan","year":"2019","unstructured":"Khan, M. Z., Haider, S., Mansoor, S., & Amin, I. (2019). Targeting plant ssDNA viruses with engineered miniature CRISPR-Cas14a. Trends in Biotechnology, 37, 800\u2013804.","journal-title":"Trends in Biotechnology"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","volume":"9","author":"M Colomer-Lluch","year":"2018","unstructured":"Colomer-Lluch, M., Ruiz, A., Moris, A., & Prado, J. G. (2018). Restriction factors: From intrinsic viral restriction to shaping cellular immunity against HIV-1. Frontiers in Immunology, 9, 2876.","journal-title":"Frontiers in Immunology"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","volume":"23","author":"F Zhang","year":"2014","unstructured":"Zhang, F., Wen, Y., & Guo, X. (2014). CRISPR\/Cas9 for genome editing: Progress, implications and challenges. Human Molecular Genetics, 23, R40\u2013R46.","journal-title":"Human Molecular Genetics"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/420116a","volume":"420","author":"E Check","year":"2002","unstructured":"Check, E. (2002). A tragic setback. Nature, 420, 116\u2013118.","journal-title":"Nature"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018). Delivering CRISPR: A review of the challenges and approaches. Drug Delivery, 25, 1234\u20131257.","journal-title":"Drug Delivery"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3350\/cmh.2013.19.1.17","volume":"19","author":"CW Kim","year":"2013","unstructured":"Kim, C. W., & Chang, K. M. (2013). Hepatitis C virus: Virology and life cycle. Clinical and Molecular Hepatology, 19, 17\u201325.","journal-title":"Clinical and Molecular Hepatology"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3390\/v7072808","volume":"7","author":"E Sesmero","year":"2015","unstructured":"Sesmero, E., & Thorpe, I. F. (2015). Using the hepatitis C virus RNA-dependent RNA polymerase as a model to understand viral polymerase structure, function and dynamics. Viruses-Basel, 7, 3974\u20133994.","journal-title":"Viruses-Basel"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.virusres.2017.01.003","volume":"244","author":"B Moyo","year":"2018","unstructured":"Moyo, B., Bloom, K., Scott, T., Ely, A., & Arbuthnot, P. (2018). Advances with using CRISPR\/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus. Virus Research, 244, 311\u2013320.","journal-title":"Virus Research"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"111239","DOI":"10.1016\/j.biopha.2021.111239","volume":"136","author":"MU Ashraf","year":"2021","unstructured":"Ashraf, M. U., Salman, H. M., Khalid, M. F., Khan, M. H. F., Anwar, S., Afzal, S., Idrees, M., & Chaudhary, S. U. (2021). CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy. Biomedicine & Pharmacotherapy, 136, 111239.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"5_CR104","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1073\/pnas.0704894104","volume":"104","author":"G Randall","year":"2007","unstructured":"Randall, G., Panis, M., Cooper, J. D., Tellinghuisen, T. L., Sukhodolets, K. E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B. D., et al. (2007). Cellular cofactors affecting hepatitis C virus infection and replication. Proceedings of the National Academy of Sciences of the United States of America, 104, 12884\u201312889.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.chom.2009.02.001","volume":"5","author":"AW Tai","year":"2009","unstructured":"Tai, A. W., Benita, Y., Peng, L. F., Kim, S. S., Sakamoto, N., Xavier, R. J., & Chung, R. T. (2009). A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host & Microbe, 5, 298\u2013307.","journal-title":"Cell Host & Microbe"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1074\/jbc.M703988200","volume":"283","author":"L Supekova","year":"2008","unstructured":"Supekova, L., Supek, F., Lee, J., Chen, S., Gray, N., Pezacki, J. P., Schlapbach, A., & Schultz, P. G. (2008). Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. The Journal of Biological Chemistry, 283, 29\u201336.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1128\/JVI.79.21.13473-13482.2005","volume":"79","author":"I Hamamoto","year":"2005","unstructured":"Hamamoto, I., Nishimura, Y., Okamoto, T., Aizaki, H., Liu, M. Y., Mori, Y., Abe, T., Suzuki, T., Lai, M. M. C., Miyamura, T., et al. (2005). Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. Journal of Virology, 79, 13473\u201313482.","journal-title":"Journal of Virology"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4049\/jimmunol.1302563","volume":"193","author":"YL Zhao","year":"2014","unstructured":"Zhao, Y. L., Ren, Y. S., Zhang, X. P., Zhao, P., Tao, W. Y., Zhong, J., Li, Q., & Zhang, X. L. (2014). Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape. Journal of Immunology, 193, 783\u2013796.","journal-title":"Journal of Immunology"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hep.26066","volume":"57","author":"C Wilkins","year":"2013","unstructured":"Wilkins, C., Woodward, J., Lau, D. T. Y., Barnes, A., Joyce, M., McFarlane, N., McKeating, J. A., Tyrrell, D. L., & Gale, M. (2013). IFITM1 Is a tight junction protein that inhibits hepatitis C virus entry. Hepatology, 57, 461\u2013469.","journal-title":"Hepatology"},{"key":"5_CR110","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/hep.26500","volume":"58","author":"TN Bukong","year":"2013","unstructured":"Bukong, T. N., Kodys, K., & Szabo, G. (2013). Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. Hepatology, 58, 1569\u20131579.","journal-title":"Hepatology"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/hep.25908","volume":"56","author":"P Metz","year":"2012","unstructured":"Metz, P., Dazert, E., Ruggieri, A., Mazur, J., Kaderali, L., Kaul, A., Zeuge, U., Windisch, M. P., Trippler, M., Lohmann, V., et al. (2012). Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Hepatology, 56, 2082\u20132093.","journal-title":"Hepatology"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1566524013666131118111719","volume":"14","author":"T Amet","year":"2014","unstructured":"Amet, T., Byrd, D., Hu, N., Sun, Q., Li, F., Zhao, Y., Hu, S., Grantham, A., & Yu, Q. (2014). BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus. Current Molecular Medicine, 14, 349\u2013360.","journal-title":"Current Molecular Medicine"},{"key":"5_CR113","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.antiviral.2013.01.009","volume":"98","author":"XB Pan","year":"2013","unstructured":"Pan, X. B., Qu, X. W., Jiang, D., Zhao, X. L., Han, J. C., & Wei, L. (2013). BST2\/Tetherin inhibits hepatitis C virus production in human hepatoma cells. Antiviral Research, 98, 54\u201360.","journal-title":"Antiviral Research"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000445852","volume":"43","author":"German Advisory Committee Blood, SAoPTbB","year":"2016","unstructured":"German Advisory Committee Blood, SAoPTbB. (2016). Human immunodeficiency virus (HIV). Transfusion Medicine and Hemotherapy, 43, 203\u2013222.","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1586\/14787210.2014.910112","volume":"12","author":"M Pace","year":"2014","unstructured":"Pace, M., & Frater, J. (2014). A cure for HIV: Is it in sight? Expert Review of Anti-Infective Therapy, 12, 783\u2013791.","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.omtn.2020.05.030","volume":"21","author":"L Yin","year":"2020","unstructured":"Yin, L., Zhao, F., Sun, H., Wang, Z., Huang, Y., Zhu, W., Xu, F., Mei, S., Liu, X., Zhang, D., et al. (2020). CRISPR-Cas13a inhibits HIV-1 infection. Molecular Therapy\u00a0-\u00a0Nucleic Acids, 21, 147\u2013155.","journal-title":"Molecular Therapy\u00a0-\u00a0Nucleic Acids"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1742-4690-3-57","volume":"3","author":"EM Westerhout","year":"2006","unstructured":"Westerhout, E. M., Ter Brake, O., & Berkhout, B. (2006). The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology, 3, 57\u201365.","journal-title":"Retrovirology"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1038\/ncomms7413","volume":"6","author":"HK Liao","year":"2015","unstructured":"Liao, H. K., Gu, Y., Diaz, A., Marlett, J., Takahashi, Y., Li, M., Suzuki, K., Xu, R., Hishida, T., Chang, C. J., et al. (2015). Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nature Communications, 6, 6413.","journal-title":"Nature Communications"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"WH Hu","year":"2014","unstructured":"Hu, W. H., Kaminski, R., Yang, F., Zhang, Y. G., Cosentino, L., Li, F., Luo, B. A., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J., et al. (2014). RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proceedings of the National Academy\u00a0of Sciences United States of America, 111, 11461\u201311466.","journal-title":"Proceedings of the National Academy\u00a0of Sciences United States of America"},{"key":"5_CR120","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/srep02510","volume":"3","author":"H Ebina","year":"2013","unstructured":"Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013). Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Scientific Reports (UK), 3, 2510.","journal-title":"Scientific Reports (UK)"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/1348-0421.12395","volume":"60","author":"S Ueda","year":"2016","unstructured":"Ueda, S., Ebina, H., Kanemura, Y., Misawa, N., & Koyanagi, Y. (2016). Anti-HIV-1 potency of the CRISPR\/Cas9 system insufficient to fully inhibit viral replication. Microbiology and Immunology, 60, 483\u2013496.","journal-title":"Microbiology and Immunology"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"29530","DOI":"10.1038\/srep29530","volume":"6","author":"KE Yoder","year":"2016","unstructured":"Yoder, K. E., & Bundschuh, R. (2016). Host double strand break repair generates HIV-1 strains resistant to CRISPR\/Cas9. Scientific Reports, 6, 29530.","journal-title":"Scientific Reports"},{"key":"5_CR123","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","volume":"25","author":"C Yin","year":"2017","unstructured":"Yin, C., Zhang, T., Qu, X., Zhang, Y., Putatunda, R., Xiao, X., Li, F., Xiao, W., Zhao, H., Dai, S., et al. (2017). In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Molecular Therapy, 25, 1168\u20131186.","journal-title":"Molecular Therapy"},{"key":"5_CR124","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/gt.2016.41","volume":"23","author":"R Kaminski","year":"2016","unstructured":"Kaminski, R., Bella, R., Yin, C., Otte, J., Ferrante, P., Gendelman, H. E., Li, H., Booze, R., Gordon, J., Hu, W., et al. (2016). Excision of HIV-1 DNA by gene editing: A proof-of-concept in vivo study. Gene Therapy, 23, 690\u2013695.","journal-title":"Gene Therapy"},{"key":"5_CR125","doi-asserted-by":"publisher","first-page":"22555","DOI":"10.1038\/srep22555","volume":"6","author":"R Kaminski","year":"2016","unstructured":"Kaminski, R., Chen, Y., Fischer, T., Tedaldi, E., Napoli, A., Zhang, Y., Karn, J., Hu, W., & Khalili, K. (2016). Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing. Scientific Reports, 6, 22555.","journal-title":"Scientific Reports"},{"key":"5_CR126","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","volume":"12","author":"W Zhu","year":"2015","unstructured":"Zhu, W., Lei, R., Le Duff, Y., Li, J., Guo, F., Wainberg, M. A., & Liang, C. (2015). The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology, 12, 22.","journal-title":"Retrovirology"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.celrep.2016.03.042","volume":"15","author":"Z Wang","year":"2016","unstructured":"Wang, Z., Pan, Q. H., Gendron, P., Zhu, W. J., Guo, F., Cen, S., Wainberg, M. A., & Liang, C. (2016). CRISPR\/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escape. Cell Reports, 15, 481\u2013489.","journal-title":"Cell Reports"},{"key":"5_CR128","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/mt.2016.24","volume":"24","author":"G Wang","year":"2016","unstructured":"Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016). CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Molecular Therapy, 24, 522\u2013526.","journal-title":"Molecular Therapy"},{"key":"5_CR129","doi-asserted-by":"publisher","first-page":"e01135","DOI":"10.1128\/JVI.01135-18","volume":"92","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Wang, W. Z., Cui, Y. C., Pan, Q. H., Zhu, W. J., Gendron, P., Guo, F., Cen, S., Witcher, M., & Liang, C. (2018). HIV-1 employs multiple mechanisms to resist Cas9\/single guide RNA targeting the viral primer binding site. Journal of Virology, 92, e01135\u2013e01118.","journal-title":"Journal of Virology"},{"key":"5_CR130","doi-asserted-by":"publisher","first-page":"41968","DOI":"10.1038\/srep41968","volume":"7","author":"RJ Lebbink","year":"2017","unstructured":"Lebbink, R. J., de Jong, D. C. M., Wolters, F., Kruse, E. M., van Ham, P. M., Wiertz, E. J. H. J., & Nijhuis, M. (2017). Combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Scientific Reports (UK), 7, 41968.","journal-title":"Scientific Reports (UK)"},{"key":"5_CR131","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","volume":"17","author":"G Wang","year":"2016","unstructured":"Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016). A combinatorial CRISPR-Cas9 attack on HIV-1 DNA extinguishes all infectious provirus in infected T cell cultures. Cell Reports, 17, 2819\u20132826.","journal-title":"Cell Reports"},{"key":"5_CR132","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.coviro.2019.07.001","volume":"38","author":"AT Das","year":"2019","unstructured":"Das, A. T., Binda, C. S., & Berkhout, B. (2019). Elimination of infectious HIV DNA by CRISPR-Cas9. Current Opinion in Virology, 38, 81\u201388.","journal-title":"Current Opinion in Virology"},{"key":"5_CR133","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/v12030330","volume":"12","author":"CS Binda","year":"2020","unstructured":"Binda, C. S., Klaver, B., Berkhout, B., & Das, A. T. (2020). CRISPR-Cas9 Dual-gRNA attack causes mutation, excision and inversion of the HIV-1 proviral DNA. Viruses, 12, 330.","journal-title":"Viruses"},{"key":"5_CR134","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/v11030255","volume":"11","author":"G Darcis","year":"2019","unstructured":"Darcis, G., Binda, C. S., Klaver, B., Herrera-Carrillo, E., Berkhout, B., & Das, A. T. (2019). The impact of HIV-1 genetic diversity on CRISPR-Cas9 antiviral activity and viral escape. Viruses, 11, 255.","journal-title":"Viruses"},{"key":"5_CR135","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13059-015-0824-9","volume":"16","author":"RD Fagerlund","year":"2015","unstructured":"Fagerlund, R. D., Staals, R. H., & Fineran, P. C. (2015). The Cpf1 CRISPR-Cas protein expands genome-editing tools. Genome Biology, 16, 251.","journal-title":"Genome Biology"},{"key":"5_CR136","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/15476286.2018.1551703","volume":"15","author":"Z Gao","year":"2018","unstructured":"Gao, Z., Herrera-Carrillo, E., & Berkhout, B. (2018). Improvement of the CRISPR-Cpf1 system with ribozyme-processed crRNA. RNA Biology, 15, 1458\u20131467.","journal-title":"RNA Biology"},{"key":"5_CR137","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/mt.2015.202","volume":"24","author":"SM Saayman","year":"2016","unstructured":"Saayman, S. M., Lazar, D. C., Scott, T. A., Hart, J. R., Takahashi, M., Burnett, J. C., Planelles, V., Morris, K. V., & Weinberg, M. S. (2016). Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex. Molecular Therapy, 24, 488\u2013498.","journal-title":"Molecular Therapy"},{"key":"5_CR138","doi-asserted-by":"publisher","first-page":"16277","DOI":"10.1038\/srep16277","volume":"5","author":"YG Zhang","year":"2015","unstructured":"Zhang, Y. G., Yin, C. R., Zhang, T., Li, F., Yang, W. S., Kaminski, R., Fagan, P. R., Putatunda, R., Young, W. B., Khalili, K., et al. (2015). CRISPR\/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Scientific Reports (UK), 5, 16277.","journal-title":"Scientific Reports (UK)"},{"key":"5_CR139","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/mt.2015.213","volume":"24","author":"P Limsirichai","year":"2016","unstructured":"Limsirichai, P., Gaj, T., & Schaffer, D. V. (2016). CRISPR-mediated activation of latent HIV-1 expression. Molecular Therapy, 24, 499\u2013507.","journal-title":"Molecular Therapy"},{"key":"5_CR140","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/S1525-0016(16)34302-7","volume":"23","author":"SM Saayman","year":"2015","unstructured":"Saayman, S. M., Lazar, D. C., Scott, T. A., Burnett, J., Takahashi, M., Weinberg, M. S., & Morris, K. V. (2015). Potent and targeted activation of latent HIV-1 using multiplexed guide RNAs and the CRISPR\/dCas9 activator complex. Molecular Therapy, 23, S276\u2013S276.","journal-title":"Molecular Therapy"},{"key":"5_CR141","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","volume":"270","author":"F Cocchi","year":"1995","unstructured":"Cocchi, F., Devico, A. L., Garzinodemo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995). Identification of rantes, Mip-1-Alpha, and Mip-1-Beta as the major hiv-suppressive factors produced by Cd8(+) T-cells. Science, 270, 1811\u20131815.","journal-title":"Science"},{"key":"5_CR142","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","volume":"117","author":"K Allers","year":"2010","unstructured":"Allers, K., Hutter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., & Schneider, T. (2010). Evidence for the cure of HIV infection by CCR5-delta32\/delta32 stem cell transplantation. Blood, 117, 2791\u20132799.","journal-title":"Blood"},{"key":"5_CR143","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G Hutter","year":"2009","unstructured":"Hutter, G., Nowak, D., Mossner, M., Ganepola, S., Mussig, A., Allers, K., Schneider, T., Hofmann, J., Kucherer, C., Blau, O., et al. (2009). Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. The New England Journal of Medicine, 360, 692\u2013698.","journal-title":"The New England Journal of Medicine"},{"key":"5_CR144","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li, C., Guan, X. M., Du, T., Jin, W., Wu, B., Liu, Y. L., Wang, P., Hu, B. D., Griffin, G. E., Shattock, R. J., et al. (2015). Inhibition of HIV-1 infection of primary CD4(+) T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. Journal of General Virology, 96, 2381\u20132393.","journal-title":"Journal of General Virology"},{"key":"5_CR145","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1073\/pnas.1407473111","volume":"111","author":"L Ye","year":"2014","unstructured":"Ye, L., Wang, J. M., Beyer, A. I., Teque, F., Cradick, T. J., Qi, Z. X., Chang, J. C., Bao, G., Muench, M. O., Yu, J. W., et al. (2014). Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5 Delta 32 mutation confers resistance to HIV infection. Proceedings of the National Academy of Sciences of the United States of America, 111, 9591\u20139596.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR146","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","volume":"25","author":"L Xu","year":"2017","unstructured":"Xu, L., Yang, H., Gao, Y., Chen, Z., Xie, L., Liu, Y., Liu, Y., Wang, X., Li, H., Lai, W., et al. (2017). CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo. Molecular Therapy, 25, 1782\u20131789.","journal-title":"Molecular Therapy"},{"key":"5_CR147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022020","volume":"6","author":"R Nedellec","year":"2011","unstructured":"Nedellec, R., Coetzer, M., Lederman, M. M., Offord, R. E., Hartley, O., & Mosier, D. E. (2011). Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use. PLoS One, 6, e22020.","journal-title":"PLoS One"},{"key":"5_CR148","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.185.4.621","volume":"185","author":"RI Connor","year":"1997","unstructured":"Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997). Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. The Journal of Experimental Medicine, 185, 621\u2013628.","journal-title":"The Journal of Experimental Medicine"},{"key":"5_CR149","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/aid.2008.0252","volume":"25","author":"W Huang","year":"2009","unstructured":"Huang, W., Toma, J., Stawiski, E., Fransen, S., Wrin, T., Parkin, N., Whitcomb, J. M., Coakley, E., Hecht, F. M., Deeks, S. G., et al. (2009). Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Research and Human Retroviruses, 25, 795\u2013802.","journal-title":"AIDS Research and Human Retroviruses"},{"key":"5_CR150","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.1512503112","volume":"112","author":"K Schumann","year":"2015","unstructured":"Schumann, K., Lin, S., Boyer, E., Simeonov, D. R., Subramaniam, M., Gate, R. E., Haliburton, G. E., Yee, C. J., Bluestone, J. A., Doudna, J. A., et al. (2015). Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proceedings of the National Academy of Sciences of the United States of America, 112, 10437\u201310442.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR151","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12977-017-0375-0","volume":"14","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Chen, S., Xiao, Q., Liu, Z., Liu, S., Hou, P., Zhou, L., Hou, W., Ho, W., Li, C., et al. (2017). Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection. Retrovirology, 14, 51.","journal-title":"Retrovirology"},{"key":"5_CR152","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13578-017-0174-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Chen, S., Jin, X., Wang, Q., Yang, K., Li, C., Xiao, Q., Hou, P., Liu, S., Wu, S., et al. (2017). Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection. Cell & Bioscience, 7, 47.","journal-title":"Cell & Bioscience"},{"key":"5_CR153","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.exphem.2006.04.002","volume":"34","author":"A Dar","year":"2006","unstructured":"Dar, A., Kollet, O., & Lapidot, T. (2006). Mutual, reciprocal SDF-1\/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD\/SCID chimeric mice. Experimental Hematology, 34, 967\u2013975.","journal-title":"Experimental Hematology"},{"key":"5_CR154","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1073\/pnas.93.25.14726","volume":"93","author":"T Nagasawa","year":"1996","unstructured":"Nagasawa, T., Nakajima, T., Tachibana, K., Iizasa, H., Bleul, C. C., Yoshie, O., Matsushima, K., Yoshida, N., Springer, T. A., & Kishimoto, T. (1996). Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proceedings of the National Academy of Sciences of the United States of America, 93, 14726\u201314729.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR155","doi-asserted-by":"publisher","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","volume":"2","author":"MH Malim","year":"2012","unstructured":"Malim, M. H., & Bieniasz, P. D. (2012). HIV restriction factors and mechanisms of evasion. Cold Spring Harbor Perspectives in Medicine, 2, a006940.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"5_CR156","doi-asserted-by":"crossref","first-page":"E7249","DOI":"10.1073\/pnas.1424236112","volume":"112","author":"HP Bogerd","year":"2015","unstructured":"Bogerd, H. P., Kornepati, A. V., Marshall, J. B., Kennedy, E. M., & Cullen, B. R. (2015). Specific induction of endogenous viral restriction factors using CRISPR\/Cas-derived transcriptional activators. Proceedings of the National Academy of Sciences of the United States of America, 112, E7249\u2013E7256.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR157","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/v13030423","volume":"13","author":"Z Kruize","year":"2021","unstructured":"Kruize, Z., van Nuenen, A. C., van Wijk, S. W., Girigorie, A. F., van Dort, K. A., Booiman, T., & Kootstra, N. A. (2021). Nef obtained from individuals with HIV-1 vary in their ability to antagonize SERINC3-and SERINC5-mediated HIV-1 restriction. Viruses-Basel, 13, 423.","journal-title":"Viruses-Basel"},{"key":"5_CR158","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature15400","volume":"526","author":"Y Usami","year":"2015","unstructured":"Usami, Y., Wu, Y., & Gottlinger, H. G. (2015). SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature, 526, 218\u2013223.","journal-title":"Nature"},{"key":"5_CR159","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.omtn.2020.01.028","volume":"19","author":"H Li","year":"2020","unstructured":"Li, H., Wang, S., Dong, X., Li, Q., Li, M., Li, J., Guo, Y., Jin, X., Zhou, Y., Song, H., et al. (2020). CRISPR-Cas13a cleavage of dengue virus NS3 gene efficiently inhibits viral replication. Molecular Therapy\u00a0-\u00a0Nucleic Acids, 19, 1460\u20131469.","journal-title":"Molecular Therapy\u00a0-\u00a0Nucleic Acids"},{"key":"5_CR160","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.omtm.2021.04.014","volume":"21","author":"E Singsuksawat","year":"2021","unstructured":"Singsuksawat, E., Onnome, S., Posiri, P., Suphatrakul, A., Srisuk, N., Nantachokchawapan, R., Praneechit, H., Sae-Kow, C., Chidpratum, P., Hongeng, S., et al. (2021). Potent programmable antiviral against dengue virus in primary human cells by Cas13b RNP with short spacer and delivery by virus-like particle. Molecular Therapy\u00a0-\u00a0Methods\u00a0&\u00a0Clinical Development., 21, 729\u2013740.","journal-title":"Molecular Therapy\u00a0-\u00a0Methods\u00a0&\u00a0Clinical Development."},{"key":"5_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007287","volume":"14","author":"KZ Wang","year":"2018","unstructured":"Wang, K. Z., Zou, C. L., Wang, X. J., Huang, C. X., Feng, T. T., Pan, W., Wu, Q. H., Wang, P. H., & Dai, J. F. (2018). Interferon-stimulated TRIM69 interrupts dengue virus replication by ubiquitinating viral nonstructural protein 3. PLoS Pathogens, 14, e1007287.","journal-title":"PLoS Pathogens"},{"key":"5_CR162","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","volume":"181","author":"TR Abbott","year":"2020","unstructured":"Abbott, T. R., Dhamdhere, G., Liu, Y. X., Lin, X. Q., Goudy, L., Zeng, L. P., Chemparathy, A., Chmura, S., Heaton, N. S., Debs, R., et al. (2020). Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell, 181, 865\u2013876.e12.","journal-title":"Cell"},{"key":"5_CR163","doi-asserted-by":"publisher","unstructured":"Blanchard, E. L., Vanover, D., Bawage, S. S., Tiwari, P. M., Rotolo, L., Beyersdorf, J., Peck, H. E., Bruno, N. C., Hincapie, R., Michel, F., et al. (2021). Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-021-00822-w","DOI":"10.1038\/s41587-021-00822-w"},{"key":"5_CR164","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.celrep.2018.03.045","volume":"23","author":"J Han","year":"2018","unstructured":"Han, J., Perez, J. T., Chen, C., Li, Y., Benitez, A., Kandasamy, M., Lee, Y., Andrade, J., tenOever, B., & Manicassamy, B. (2018). Genome-wide CRISPR\/Cas9 screen identifies host factors essential for influenza virus replication. Cell Reports, 23, 596\u2013607.","journal-title":"Cell Reports"},{"key":"5_CR165","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41467-019-13965-x","volume":"11","author":"B Li","year":"2020","unstructured":"Li, B., Clohisey, S. M., Chia, B. S., Wang, B., Cui, A., Eisenhaure, T., Schweitzer, L. D., Hoover, P., Parkinson, N. J., Nachshon, A., et al. (2020). Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection. Nature Communications, 11, 164.","journal-title":"Nature Communications"},{"key":"5_CR166","doi-asserted-by":"publisher","first-page":"8512363","DOI":"10.1155\/2019\/8512363","volume":"2019","author":"L Westera","year":"2019","unstructured":"Westera, L., Jennings, A. M., Maamary, J., Schwemmle, M., Garcia-Sastre, A., & Bortz, E. (2019). Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase. Advances in Virology, 2019, 8512363.","journal-title":"Advances in Virology"},{"key":"5_CR167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41577-020-00482-y","volume":"21","author":"E Gea-Mallorqui","year":"2021","unstructured":"Gea-Mallorqui, E. (2021). Mapping host restriction of SARS-CoV-2. Nature Reviews. Immunology, 21, 3.","journal-title":"Nature Reviews. Immunology"},{"key":"5_CR168","doi-asserted-by":"publisher","unstructured":"Martin-Sancho, L., Lewinski, M. K., Pache, L., Stoneham, C. A., Yin, X., Becker, M. E., Pratt, D., Churas, C., Rosenthal, S. B., Liu, S., et al. (2021). Functional landscape of SARS-CoV-2 cellular restriction. Molecular Cell. https:\/\/doi.org\/10.1101\/2020.09.29.319566","DOI":"10.1101\/2020.09.29.319566"},{"key":"5_CR169","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","volume":"76","author":"CA Freije","year":"2019","unstructured":"Freije, C. A., Myhrvold, C., Boehm, C. K., Lin, A. E., Welch, N. L., Carter, A., Metsky, H. C., Luo, C. Y., Abudayyeh, O. O., Gootenberg, J. S., et al. (2019). Programmable inhibition and detection of RNA viruses using Cas13. Molecular Cell, 76, 826\u2013837.e11.","journal-title":"Molecular Cell"},{"key":"5_CR170","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00705-008-0278-4","volume":"154","author":"AJ Davison","year":"2009","unstructured":"Davison, A. J., Eberle, R., Ehlers, B., Hayward, G. S., McGeoch, D. J., Minson, A. C., Pellett, P. E., Roizman, B., Studdert, M. J., & Thiry, E. (2009). The order herpesvirales. Archives of Virology, 154, 171\u2013177.","journal-title":"Archives of Virology"},{"key":"5_CR171","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12250-017-4108-2","volume":"32","author":"K Lan","year":"2017","unstructured":"Lan, K., & Luo, M. H. (2017). Herpesviruses: Epidemiology, pathogenesis, and interventions. Virologica Sinica, 32, 347\u2013348.","journal-title":"Virologica Sinica"},{"key":"5_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.38","volume":"3","author":"SR Lin","year":"2014","unstructured":"Lin, S. R., Yang, H. C., Kuo, Y. T., Liu, C. J., Yang, T. Y., Sung, K. C., Lin, Y. Y., Wang, H. Y., Wang, C. C., Shen, Y. C., et al. (2014). The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Molecular Therapy\u00a0-\u00a0Nucleic Acids, 3, e186.","journal-title":"Molecular Therapy\u00a0-\u00a0Nucleic Acids"},{"key":"5_CR173","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.virusres.2017.04.019","volume":"244","author":"KS Yuen","year":"2018","unstructured":"Yuen, K. S., Wang, Z. M., Wong, N. M., Zhang, Z. Q., Cheng, T. F., Lui, W. Y., Chan, C. P., & Jin, D. Y. (2018). Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9. Virus Research, 244, 296\u2013303.","journal-title":"Virus Research"},{"key":"5_CR174","doi-asserted-by":"publisher","first-page":"13157","DOI":"10.1073\/pnas.1410785111","volume":"111","author":"J Wang","year":"2014","unstructured":"Wang, J., & Quake, S. R. (2014). RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proceedings of the National Academy of Sciences of the United States of America, 111, 13157\u201313162.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR175","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12985-021-01527-x","volume":"18","author":"CO Haddad","year":"2021","unstructured":"Haddad, C. O., Kalt, I., Shovman, Y., Xia, L., Schlesinger, Y., Sarid, R., & Parnas, O. (2021). Targeting the Kaposi\u2019s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells. Virology Journal, 18, 56.","journal-title":"Virology Journal"},{"key":"5_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen, F. R., Kruse, E. M., Hooykaas, M. J., Bruggeling, C. E., Schurch, A. C., van Ham, P. M., Imhof, S. M., Nijhuis, M., Wiertz, E. J., & Lebbink, R. J. (2016). CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathogens, 12, e1005701.","journal-title":"PLoS Pathogens"},{"key":"5_CR177","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1038\/s41467-020-17936-5","volume":"11","author":"M Aubert","year":"2020","unstructured":"Aubert, M., Strongin, D. E., Roychoudhury, P., Loprieno, M. A., Haick, A. K., Klouser, L. M., Stensland, L., Huang, M. L., Makhsous, N., Tait, A., et al. (2020). Gene editing and elimination of latent herpes simplex virus in vivo. Nature Communications, 11, 4148.","journal-title":"Nature Communications"},{"key":"5_CR178","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1128\/JVI.01027-15","volume":"89","author":"Y Bai","year":"2015","unstructured":"Bai, Y., Xuan, B., Liu, H., Zhong, J., Yu, D., & Qian, Z. (2015). Tuberous sclerosis complex protein 2-independent activation of mTORC1 by human cytomegalovirus pUL38. Journal of Virology, 89, 7625\u20137635.","journal-title":"Journal of Virology"},{"key":"5_CR179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004503","volume":"10","author":"KE Johnson","year":"2014","unstructured":"Johnson, K. E., Bottero, V., Flaherty, S., Dutta, S., Singh, V. V., & Chandran, B. (2014). IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathogens, 10, e1004503.","journal-title":"PLoS Pathogens"},{"key":"5_CR180","doi-asserted-by":"publisher","first-page":"e01553","DOI":"10.1128\/mBio.01553-16","volume":"7","author":"BA Diner","year":"2016","unstructured":"Diner, B. A., Lum, K. K., Toettcher, J. E., & Cristea, I. M. (2016). Viral DNA sensors IFI16 and cyclic GMP-AMP synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during herpesvirus infection. mBio, 7, e01553\u2013e01516.","journal-title":"mBio"},{"key":"5_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004090","volume":"10","author":"Y Bi","year":"2014","unstructured":"Bi, Y., Sun, L., Gao, D., Ding, C., Li, Z., Li, Y., Cun, W., & Li, Q. (2014). High-efficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS Pathogens, 10, e1004090.","journal-title":"PLoS Pathogens"},{"key":"5_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004993","volume":"11","author":"D Avey","year":"2015","unstructured":"Avey, D., Tepper, S., Li, W., Turpin, Z., & Zhu, F. (2015). Phosphoproteomic analysis of KSHV-infected cells reveals roles of ORF45-activated RSK during lytic replication. PLoS Pathogens, 11, e1004993.","journal-title":"PLoS Pathogens"},{"key":"5_CR183","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1128\/JVI.00060-16","volume":"90","author":"T Kanda","year":"2016","unstructured":"Kanda, T., Furuse, Y., Oshitani, H., & Kiyono, T. (2016). Highly efficient CRISPR\/Cas9-mediated cloning and functional characterization of gastric cancer-derived Epstein-Barr virus strains. Journal of Virology, 90, 4383\u20134393.","journal-title":"Journal of Virology"},{"key":"5_CR184","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1128\/JVI.00139-16","volume":"90","author":"CJ Bierle","year":"2016","unstructured":"Bierle, C. J., Anderholm, K. M., Ben Wang, J., McVoy, M. A., & Schleiss, M. R. (2016). Targeted mutagenesis of guinea pig cytomegalovirus using CRISPR\/Cas9-mediated gene editing. Journal of Virology, 90, 6989\u20136998.","journal-title":"Journal of Virology"},{"key":"5_CR185","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1128\/JVI.02858-15","volume":"90","author":"I Murrell","year":"2016","unstructured":"Murrell, I., Wilkie, G. S., Davison, A. J., Statkute, E., Fielding, C. A., Tomasec, P., Wilkinson, G. W., & Stanton, R. J. (2016). Genetic stability of bacterial artificial chromosome-derived human cytomegalovirus during culture in vitro. Journal of Virology, 90, 3929\u20133943.","journal-title":"Journal of Virology"},{"key":"5_CR186","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gr.161638.113","volume":"24","author":"TO Auer","year":"2014","unstructured":"Auer, T. O., Duroure, K., De Cian, A., Concordet, J. P., & Del Bene, F. (2014). Highly efficient CRISPR\/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Research, 24, 142\u2013153.","journal-title":"Genome Research"},{"key":"5_CR187","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1101\/gr.145441.112","volume":"23","author":"M Maresca","year":"2013","unstructured":"Maresca, M., Lin, V. G., Guo, N., & Yang, Y. (2013). Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Research, 23, 539\u2013546.","journal-title":"Genome Research"},{"key":"5_CR188","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016). In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature, 540, 144\u2013149.","journal-title":"Nature"},{"key":"5_CR189","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1099\/jgv.0.001451","volume":"101","author":"Y Gong","year":"2020","unstructured":"Gong, Y., Bi, Y. W., Li, Z. H., Li, Y. Z., Yao, Y. T., Long, Q., Pu, T., Chen, C., Liu, T. Y., Dong, S. Z., et al. (2020). High-efficiency nonhomologous insertion of a foreign gene into the herpes simplex virus genome. Journal of General Virology, 101, 982\u2013996.","journal-title":"Journal of General Virology"},{"key":"5_CR190","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/genes11020140","volume":"11","author":"S Erwood","year":"2020","unstructured":"Erwood, S., & Gu, B. (2020). Embryo-based large fragment knock-in in mammals: Why, how and what\u2019s next. Genes-Basel, 11, 140.","journal-title":"Genes-Basel"},{"key":"5_CR191","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1038\/sj.onc.1206554","volume":"22","author":"F Fehrmann","year":"2003","unstructured":"Fehrmann, F., & Laimins, L. A. (2003). Human papillomaviruses: Targeting differentiating epithelial cells for malignant transformation. Oncogene, 22, 5201\u20135207.","journal-title":"Oncogene"},{"key":"5_CR192","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ajo.12282","volume":"54","author":"I Ghosh","year":"2014","unstructured":"Ghosh, I., Mittal, S., Banerjee, D., Singh, P., Dasgupta, S., Chatterjee, S., Biswas, J., Panda, C., & Basu, P. (2014). Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program. The\u00a0Australian\u00a0and New Zealand\u00a0Journal\u00a0of Obstetrics\u00a0and Gynaecology, 54, 570\u2013575.","journal-title":"The\u00a0Australian\u00a0and New Zealand\u00a0Journal\u00a0of Obstetrics\u00a0and Gynaecology"},{"key":"5_CR193","first-page":"325","volume":"102","author":"N Munoz","year":"2010","unstructured":"Munoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O. E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010). Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women. Journal\u00a0of the National Cancer\u00a0Institute, 102, 325\u2013339.","journal-title":"Journal\u00a0of the National Cancer\u00a0Institute"},{"key":"5_CR194","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1128\/JVI.01879-14","volume":"88","author":"EM Kennedy","year":"2014","unstructured":"Kennedy, E. M., Kornepati, A. V. R., Goldstein, M., Bogerd, H. P., Poling, B. C., Whisnant, A. W., Kastan, M. B., & Cullen, B. R. (2014). Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease. Journal of Virology, 88, 11965\u201311972.","journal-title":"Journal of Virology"},{"key":"5_CR195","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","volume":"450","author":"S Zhen","year":"2014","unstructured":"Zhen, S., Hua, L., Takahashi, Y., Narita, S., Liu, Y. H., & Li, Y. (2014). In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9. Biochemical\u00a0and Biophysical Research Communications, 450, 1422\u20131426.","journal-title":"Biochemical\u00a0and Biophysical Research Communications"},{"key":"5_CR196","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virusres.2016.11.014","volume":"231","author":"SS Porter","year":"2017","unstructured":"Porter, S. S., Stepp, W. H., Stamos, J. D., & McBride, A. A. (2017). Host cell restriction factors that limit transcription and replication of human papillomavirus. Virus Research, 231, 10\u201320.","journal-title":"Virus Research"},{"key":"5_CR197","doi-asserted-by":"publisher","first-page":"e00102","DOI":"10.1128\/JVI.00102-17","volume":"91","author":"D Das","year":"2017","unstructured":"Das, D., Smith, N., Wang, X., & Morgan, I. M. (2017). The deacetylase SIRT1 regulates the replication properties of human papillomavirus 16 E1 and E2. Journal of Virology, 91, e00102\u2013e00117.","journal-title":"Journal of Virology"},{"key":"5_CR198","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.humpath.2016.10.019","volume":"61","author":"E Peta","year":"2017","unstructured":"Peta, E., Cappellesso, R., Masi, G., Sinigaglia, A., Trevisan, M., Grassi, A., Di Camillo, B., Vassarotto, E., Fassina, A., Palu, G., et al. (2017). Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma. Human Pathology, 61, 33\u201340.","journal-title":"Human Pathology"},{"key":"5_CR199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005934","volume":"12","author":"M DeSmet","year":"2016","unstructured":"DeSmet, M., Kanginakudru, S., Rietz, A., Wu, W. H., Roden, R., & Androphy, E. J. (2016). The replicative consequences of papillomavirus E2 protein binding to the origin replication factor ORC2. PLoS Pathogens, 12, e1005934.","journal-title":"PLoS Pathogens"},{"key":"5_CR200","doi-asserted-by":"publisher","first-page":"e01644","DOI":"10.1128\/mBio.01644-16","volume":"7","author":"CC McKinney","year":"2016","unstructured":"McKinney, C. C., Kim, M. J., Chen, D., & McBride, A. A. (2016). Brd4 activates early viral transcription upon human papillomavirus 18 infection of primary keratinocytes. MBio, 7, e01644\u2013e01616.","journal-title":"MBio"},{"key":"5_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006039","volume":"12","author":"F Meuris","year":"2016","unstructured":"Meuris, F., Carthagena, L., Jaracz-Ros, A., Gaudin, F., Cutolo, P., Deback, C., Xue, Y. Z., Thierry, F., Doorbar, J., & Bachelerie, F. (2016). The CXCL12\/CXCR4 signaling pathway: A new susceptibility factor in human papillomavirus pathogenesis. PLoS Pathogens, 12, e1006039.","journal-title":"PLoS Pathogens"},{"key":"5_CR202","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po, C., Chan, H. L. Y., & Lok, A. (2014). Hepatitis B virus infection. The Lancet, 384, 2053\u20132063.","journal-title":"The Lancet"},{"key":"5_CR203","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-642-38965-8_4","volume":"193","author":"L Riviere","year":"2014","unstructured":"Riviere, L., Ducroux, A., & Buendia, M. A. (2014). The oncogenic role of hepatitis B virus. Recent Results in Cancer Research, 193, 59\u201374.","journal-title":"Recent Results in Cancer Research"},{"key":"5_CR204","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/gt.2015.2","volume":"22","author":"S Zhen","year":"2015","unstructured":"Zhen, S., Hua, L., Liu, Y. H., Gao, L. C., Fu, J., Wan, D. Y., Dong, L. H., Song, H. F., & Gao, X. (2015). Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus. Gene Therapy, 22, 404\u2013412.","journal-title":"Gene Therapy"},{"key":"5_CR205","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.7150\/ijbs.16064","volume":"12","author":"H Li","year":"2016","unstructured":"Li, H., Sheng, C., Liu, H., Liu, G., Du, X., Du, J., Zhan, L., Li, P., Yang, C., Qi, L., et al. (2016). An effective molecular target site in hepatitis B virus S gene for Cas9 cleavage and mutational inactivation. International Journal of Biological Sciences, 12, 1104\u20131113.","journal-title":"International Journal of Biological Sciences"},{"key":"5_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.68","volume":"3","author":"C Seeger","year":"2014","unstructured":"Seeger, C., & Sohn, J. A. (2014). Targeting hepatitis B virus with CRISPR\/Cas9. Molecular Therapy\u00a0-\u00a0Nucleic Acids, 3, e216.","journal-title":"Molecular Therapy\u00a0-\u00a0Nucleic Acids"},{"key":"5_CR207","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","volume":"476","author":"EM Kennedy","year":"2015","unstructured":"Kennedy, E. M., Bassit, L. C., Mueller, H., Kornepati, A. V. R., Bogerd, H. P., Nie, T., Chatterjee, P., Javanbakht, H., Schinazi, R. F., & Cullen, B. R. (2015). Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease. Virology, 476, 196\u2013205.","journal-title":"Virology"},{"key":"5_CR208","doi-asserted-by":"publisher","first-page":"10833","DOI":"10.1038\/srep10833","volume":"5","author":"V Ramanan","year":"2015","unstructured":"Ramanan, V., Shlomai, A., Cox, D. B., Schwartz, R. E., Michailidis, E., Bhatta, A., Scott, D. A., Zhang, F., Rice, C. M., & Bhatia, S. N. (2015). CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Scientific Reports, 5, 10833.","journal-title":"Scientific Reports"},{"key":"5_CR209","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00018-019-03021-8","volume":"76","author":"D Kostyushev","year":"2019","unstructured":"Kostyushev, D., Brezgin, S., Kostyusheva, A., Zarifyan, D., Goptar, I., & Chulanov, V. (2019). Orthologous CRISPR\/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus. Cellular and Molecular Life Sciences, 76, 1779\u20131794.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"5_CR210","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","volume":"118","author":"C Dong","year":"2015","unstructured":"Dong, C., Qu, L., Wang, H., Wei, L., Dong, Y., & Xiong, S. (2015). Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication. Antiviral Research, 118, 110\u2013117.","journal-title":"Antiviral Research"},{"key":"5_CR211","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.omtm.2020.11.014","volume":"20","author":"D Stone","year":"2021","unstructured":"Stone, D., Long, K. R., Loprieno, M. A., De Silva Feelixge, H. S., Kenkel, E. J., Liley, R. M., Rapp, S., Roychoudhury, P., Nguyen, T., Stensland, L., et al. (2021). CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Molecular Therapy\u00a0-\u00a0Methods\u00a0&\u00a0Clinical Development, 20, 258\u2013275.","journal-title":"Molecular Therapy\u00a0-\u00a0Methods\u00a0&\u00a0Clinical Development"},{"key":"5_CR212","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4254\/wjh.v7.i3.289","volume":"7","author":"CM Croagh","year":"2015","unstructured":"Croagh, C. M., Desmond, P. V., & Bell, S. J. (2015). Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. World Journal of Hepatology, 7, 289\u2013303.","journal-title":"World Journal of Hepatology"},{"key":"5_CR213","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","volume":"60","author":"S Nkongolo","year":"2014","unstructured":"Nkongolo, S., Ni, Y., Lempp, F. A., Kaufman, C., Lindner, T., Esser-Nobis, K., Lohmann, V., Mier, W., Mehrle, S., & Urban, S. (2014). Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. Journal of Hepatology, 60, 723\u2013731.","journal-title":"Journal of Hepatology"},{"key":"5_CR214","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan, H., Zhong, G. C., Xu, G. W., He, W. H., Jing, Z. Y., Gao, Z. C., Huang, Y., Qi, Y. H., Peng, B., Wang, H. M., et al. (2012). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife, 1, e00049.","journal-title":"eLife"},{"key":"5_CR215","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1128\/AAC.01764-09","volume":"54","author":"YP Wang","year":"2010","unstructured":"Wang, Y. P., Liu, F., He, H. W., Han, Y. X., Peng, Z. G., Li, B. W., You, X. F., Song, D. Q., Li, Z. R., Yu, L. Y., et al. (2010). Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus. Antimicrobial Agents and Chemotherapy, 54, 2070\u20132077.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"5_CR216","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1093\/nar\/gkm628","volume":"35","author":"M Stahl","year":"2007","unstructured":"Stahl, M., Retzlaff, M., Nassal, M., & Beck, J. R. (2007). Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Research, 35, 6124\u20136136.","journal-title":"Nucleic Acids Research"},{"key":"5_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128401","volume":"10","author":"X Cui","year":"2015","unstructured":"Cui, X., McAllister, R., Boregowda, R., Sohn, J. A., Cortes Ledesma, F., Caldecott, K. W., Seeger, C., & Hu, J. (2015). Does tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair? PLoS One, 10, e0128401.","journal-title":"PLoS One"},{"key":"5_CR218","first-page":"E4244","volume":"111","author":"C Koniger","year":"2014","unstructured":"Koniger, C., Wingert, I., Marsmann, M., Rosler, C., Beck, J., & Nassal, M. (2014). Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proceedings of the National Academy of Sciences of the United States of America, 111, E4244\u2013E4253.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR219","doi-asserted-by":"publisher","first-page":"29297","DOI":"10.1074\/jbc.M603517200","volume":"281","author":"M Rost","year":"2006","unstructured":"Rost, M., Mann, S., Lambert, C., Doring, T., Thome, N., & Prange, R. (2006). Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation. The Journal of Biological Chemistry, 281, 29297\u201329308.","journal-title":"The Journal of Biological Chemistry"},{"key":"5_CR220","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1128\/JVI.75.11.5343-5351.2001","volume":"75","author":"C Hartmann-Stuhler","year":"2001","unstructured":"Hartmann-Stuhler, C., & Prange, R. (2001). Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein. Journal of Virology, 75, 5343\u20135351.","journal-title":"Journal of Virology"},{"key":"5_CR221","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.virol.2016.05.001","volume":"495","author":"GU Jeong","year":"2016","unstructured":"Jeong, G. U., Park, I. H., Ahn, K., & Ahn, B. Y. (2016). Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1. Virology, 495, 71\u201378.","journal-title":"Virology"},{"key":"5_CR222","doi-asserted-by":"publisher","first-page":"21840","DOI":"10.18632\/oncotarget.4808","volume":"6","author":"K Miyakawa","year":"2015","unstructured":"Miyakawa, K., Matsunaga, S., Watashi, K., Sugiyama, M., Kimura, H., Yamamoto, N., Mizokami, M., Wakita, T., & Ryo, A. (2015). Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy. Oncotarget, 6, 21840\u201321852.","journal-title":"Oncotarget"},{"key":"5_CR223","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.1128\/JVI.00933-15","volume":"89","author":"R Yan","year":"2015","unstructured":"Yan, R., Zhao, X. S., Cai, D. W., Liu, Y. J., Block, T. M., Guo, J. T., & Guo, H. T. (2015). The interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion. Journal of Virology, 89, 9200\u20139212.","journal-title":"Journal of Virology"},{"key":"5_CR224","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1038\/srep11736","volume":"5","author":"MY Lv","year":"2015","unstructured":"Lv, M. Y., Zhang, B., Shi, Y., Han, Z., Zhang, Y., Zhou, Y. L., Zhang, W. Y., Niu, J. Q., & Yu, X. F. (2015). Identification of BST-2\/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Scientific Reports (UK), 5, 11736.","journal-title":"Scientific Reports (UK)"},{"key":"5_CR225","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2019.12.009","volume":"72","author":"YX Wang","year":"2020","unstructured":"Wang, Y. X., Niklasch, M., Liu, T. T., Wang, Y., Shi, B. S., Yuan, W. J., Baumert, T. F., Yuan, Z. H., Tong, S. P., Nassal, M., et al. (2020). Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. Journal of Hepatology, 72, 865\u2013876.","journal-title":"Journal of Hepatology"},{"key":"5_CR226","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41564-019-0405-x","volume":"4","author":"C Hallez","year":"2019","unstructured":"Hallez, C., Li, X. X., Suspene, R., Thiers, V., Bouzidi, M. S., Dorobantu, C. M., Lucansky, V., Wain-Hobson, S., Gaudin, R., & Vartanian, J. P. (2019). Hypoxia-induced human deoxyribonuclease I is a cellular restriction factor of hepatitis B virus. Nature Microbiology, 4, 1196\u20131207.","journal-title":"Nature Microbiology"},{"key":"5_CR227","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/17425247.2018.1517746","volume":"15","author":"DC Luther","year":"2018","unstructured":"Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F., & Rotello, V. M. (2018). Delivery approaches for CRISPR\/Cas9 therapeutics in vivo: Advances and challenges. Expert Opinion on Drug Delivery, 15, 905\u2013913.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"5_CR228","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41596-020-0309-5","volume":"15","author":"B Wienert","year":"2020","unstructured":"Wienert, B., Wyman, S. K., Yeh, C. L. D., Conklin, B. R., & Corn, J. E. (2020). CRISPR off-target detection with DISCOVER-seq. Nature Protocols, 15, 1775\u20131799.","journal-title":"Nature Protocols"},{"key":"5_CR229","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.aav9973","volume":"364","author":"EW Zuo","year":"2019","unstructured":"Zuo, E. W., Sun, Y. D., Wei, W., Yuan, T. L., Ying, W. Q., Sun, H., Yuan, L. Y., Steinmetz, L. M., Li, Y. X., & Yang, H. (2019). Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science, 364, 289\u2013292.","journal-title":"Science"},{"key":"5_CR230","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jgg.2019.11.002","volume":"46","author":"JJ Li","year":"2019","unstructured":"Li, J. J., Hong, S. Y., Chen, W. J., Zuo, E. W., & Yang, H. (2019). Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing. Journal of Genetics and Genomics, 46, 513\u2013521.","journal-title":"Journal of Genetics and Genomics"},{"key":"5_CR231","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.aav9023","volume":"364","author":"B Wienert","year":"2019","unstructured":"Wienert, B., Wyman, S. K., Richardson, C. D., Yeh, C. D., Akcakaya, P., Porritt, M. J., Morlock, M., Vu, J. T., Kazane, K. R., Watry, H. L., et al. (2019). Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science, 364, 286\u2013289.","journal-title":"Science"},{"key":"5_CR232","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/nar\/gkx1199","volume":"46","author":"DE Ryan","year":"2018","unstructured":"Ryan, D. E., Taussig, D., Steinfeld, I., Phadnis, S. M., Lunstad, B. D., Singh, M., Vuong, X., Okochi, K. D., McCaffrey, R., Olesiak, M., et al. (2018). Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs. Nucleic Acids Research, 46, 792\u2013803.","journal-title":"Nucleic Acids Research"},{"key":"5_CR233","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.celrep.2014.09.044","volume":"9","author":"XJ Ren","year":"2014","unstructured":"Ren, X. J., Yang, Z. H., Xu, J., Sun, J., Mao, D. C., Hu, Y. H., Yang, S. J., Qiao, H. H., Wang, X., Hu, Q., et al. (2014). Enhanced specificity and efficiency of the CRISPR\/Cas9 system with optimized sgRNA parameters in drosophila. Cell Reports, 9, 1151\u20131162.","journal-title":"Cell Reports"},{"key":"5_CR234","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nchembio.2559","volume":"14","author":"H Yin","year":"2018","unstructured":"Yin, H., Song, C. Q., Suresh, S., Kwan, S. Y., Wu, Q. Q., Walsh, S., Ding, J. M., Bogorad, R. L., Zhu, L. J., Wolfe, S. A., et al. (2018). Partial DNA-guided Cas9 enables genome editing with reduced off-target activity. Nature Chemical Biology, 14, 311\u2013316.","journal-title":"Nature Chemical Biology"},{"key":"5_CR235","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201800689","volume":"14","author":"YF Wang","year":"2019","unstructured":"Wang, Y. F., Wang, B., Xie, H. H., Ren, Q. W., Liu, X. X., Li, F. F., Lv, X. J., He, X. B., Cheng, C. S., Deng, R. Z., et al. (2019). Efficient human genome editing using SaCas9 ribonucleoprotein complexes. Biotechnology Journal, 14, e1800689.","journal-title":"Biotechnology Journal"},{"key":"5_CR236","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1016\/S1525-0016(16)33539-0","volume":"24","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., & Joung, J. K. (2016). High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Molecular Therapy, 24, S288\u2013S288.","journal-title":"Molecular Therapy"},{"key":"5_CR237","doi-asserted-by":"publisher","first-page":"20969","DOI":"10.1073\/pnas.1906843116","volume":"116","author":"Y Tan","year":"2019","unstructured":"Tan, Y., Chu, A. H. Y., Bao, S., Hoang, D. A., Kebede, F. T., Xiong, W., Ji, M., Shi, J., & Zheng, Z. (2019). Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity. Proceedings of the National Academy of Sciences of the United States of America, 116, 20969\u201320976.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5_CR238","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13059-020-01989-2","volume":"21","author":"P Chen","year":"2020","unstructured":"Chen, P., Zhou, J., Wan, Y., Liu, H., Li, Y. Z., Liu, Z. X., Wang, H. J., Lei, J., Zhao, K., Zhang, Y. L., et al. (2020). A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing. Genome Biology, 21, 18.","journal-title":"Genome Biology"},{"key":"5_CR239","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J. S. (2014). Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research, 24, 1012\u20131019.","journal-title":"Genome Research"},{"key":"5_CR240","first-page":"1145","volume":"2","author":"YM Shen","year":"1982","unstructured":"Shen, Y. M., Hirschhorn, R. R., Mercer, W. E., Surmacz, E., Tsutsui, Y., Soprano, K. J., & Baserga, R. (1982). Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Molecular and Cellular Biology, 2, 1145\u20131154.","journal-title":"Molecular and Cellular Biology"},{"key":"5_CR241","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0167-4781(95)00177-8","volume":"1264","author":"WS Meaking","year":"1995","unstructured":"Meaking, W. S., Edgerton, J., Wharton, C. W., & Meldrum, R. A. (1995). Electroporation-induced damage in mammalian cell DNA. Biochimica et Biophysica Acta (BBA), 1264, 357\u2013362.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"5_CR242","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/jacs.7b11754","volume":"140","author":"SK Alsaiari","year":"2018","unstructured":"Alsaiari, S. K., Patil, S., Alyami, M., Alamoudi, K. O., Aleisa, F. A., Merzaban, J. S., Li, M., & Khashab, N. M. (2018). Endosomal escape and delivery of CRISPR\/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework. Journal of the American Chemical Society, 140, 143\u2013146.","journal-title":"Journal of the American Chemical Society"},{"key":"5_CR243","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K., Conboy, M., Park, H. M., Jiang, F. G., Kim, H. J., Dewitt, M. A., Mackley, V. A., Chang, K., Rao, A., Skinner, C., et al. (2017). Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nature Biomedical Engineering, 1, 889\u2013901.","journal-title":"Nature Biomedical Engineering"},{"key":"5_CR244","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7150\/thno.47007","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Shen, J. T., Li, D. L., & Cheng, Y. Y. (2021). Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing. Theranostics, 11, 614\u2013648.","journal-title":"Theranostics"},{"key":"5_CR245","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/v11010028","volume":"11","author":"CL Xu","year":"2019","unstructured":"Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019). Viral delivery systems for CRISPR. Viruses, 11, 28.","journal-title":"Viruses"},{"key":"5_CR246","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017). Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs, 31, 317\u2013334.","journal-title":"BioDrugs"},{"key":"5_CR247","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00335-017-9697-4","volume":"28","author":"A Cebrian-Serrano","year":"2017","unstructured":"Cebrian-Serrano, A., & Davies, B. (2017). CRISPR-Cas orthologues and variants: Optimizing the repertoire, specificity and delivery of genome engineering tools. Mammalian Genome, 28, 247\u2013261.","journal-title":"Mammalian Genome"},{"key":"5_CR248","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/14728222.2014.980236","volume":"19","author":"E Herrera-Carrillo","year":"2015","unstructured":"Herrera-Carrillo, E., & Berkhout, B. (2015). Potential mechanisms for cell-based gene therapy to treat HIV\/AIDS. Expert Opinion on Therapeutic Targets, 19, 245\u2013263.","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"5_CR249","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/v7072804","volume":"7","author":"E Herrera-Carrillo","year":"2015","unstructured":"Herrera-Carrillo, E., & Berkhout, B. (2015). Bone marrow gene therapy for HIV\/AIDS. Viruses, 7, 3910\u20133936.","journal-title":"Viruses"},{"key":"5_CR250","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/jgm.958","volume":"8","author":"S Laufs","year":"2006","unstructured":"Laufs, S., Guenechea, G., Gonzalez-Murillo, A., Zsuzsanna Nagy, K., Luz Lozano, M., del Val, C., Jonnakuty, S., Hotz-Wagenblatt, A., Jens Zeller, W., Bueren, J. A., et al. (2006). Lentiviral vector integration sites in human NOD\/SCID repopulating cells. The Journal of Gene Medicine, 8, 1197\u20131207.","journal-title":"The Journal of Gene Medicine"},{"key":"5_CR251","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi Sergi, L., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nature Biotechnology, 24, 687\u2013696.","journal-title":"Nature Biotechnology"},{"key":"5_CR252","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1172\/JCI37630","volume":"119","author":"E Montini","year":"2009","unstructured":"Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. The Journal of Clinical Investigation, 119, 964\u2013975.","journal-title":"The Journal of Clinical Investigation"},{"key":"5_CR253","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/mt.2009.16","volume":"17","author":"GP Wang","year":"2009","unstructured":"Wang, G. P., Levine, B. L., Binder, G. K., Berry, C. C., Malani, N., McGarrity, G., Tebas, P., June, C. H., & Bushman, F. D. (2009). Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells. Molecular Therapy, 17, 844\u2013850.","journal-title":"Molecular Therapy"},{"key":"5_CR254","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang, D., Mou, H., Li, S., Li, Y., Hough, S., Tran, K., Li, J., Yin, H., Anderson, D. G., Sontheimer, E. J., et al. (2015). Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of cas9-specific immune responses. Human Gene Therapy, 26, 432\u2013442.","journal-title":"Human Gene Therapy"},{"key":"5_CR255","doi-asserted-by":"publisher","first-page":"103802","DOI":"10.1016\/j.cellimm.2018.04.012","volume":"342","author":"A Annoni","year":"2019","unstructured":"Annoni, A., Gregori, S., Naldini, L., & Cantore, A. (2019). Modulation of immune responses in lentiviral vector-mediated gene transfer. Cellular Immunology, 342, 103802.","journal-title":"Cellular Immunology"},{"key":"5_CR256","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/hum.2005.16.741","volume":"16","author":"E Abordo-Adesida","year":"2005","unstructured":"Abordo-Adesida, E., Follenzi, A., Barcia, C., Sciascia, S., Castro, M. G., Naldini, L., & Lowenstein, P. R. (2005). Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Human Gene Therapy, 16, 741\u2013751.","journal-title":"Human Gene Therapy"},{"key":"5_CR257","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E., Risson, V., Fusil, F., Marnef, A., Laurent, E., Blin, J., Mournetas, V., Massourides, E., Sohier, T. J. M., Corbin, A., et al. (2019). Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nature Communications, 10, 45.","journal-title":"Nature Communications"},{"key":"5_CR258","first-page":"1436","volume":"65","author":"XJ Wang","year":"2020","unstructured":"Wang, X. J., Zhong, M. T., Liu, Y., Ma, P. X., Dang, L., Meng, Q. Z., Wan, W. W., Ma, X. D., Liu, J., Yang, G., et al. (2020). Rapid and sensitive detection of COVID-19 using CRISPR\/Cas12a-based detection with naked eye readout, CRISPR\/Cas12a-NER. Scientific Bulletin, 65, 1436\u20131439.","journal-title":"Scientific Bulletin"},{"key":"5_CR259","doi-asserted-by":"crossref","unstructured":"Joung, J., Ladha, A., Saito, M., Segel, M., Bruneau, R., Huang, M. W., Kim, N. G., Yu, X., Li, J., & Walker, B.D., et al. (2020). Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv.","DOI":"10.1101\/2020.05.04.20091231"},{"key":"5_CR260","doi-asserted-by":"crossref","unstructured":"Arizti-Sanz, J., Freije, C. A., Stanton, A. C., Boehm, C. K., Petros, B. A., Siddiqui, S., Shaw, B. M., Adams, G., Kosoko-Thoroddsen, T. F., & Kemball, M. E., et al. (2020). Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2. bioRxiv.","DOI":"10.1101\/2020.05.28.119131"}],"container-title":["Biotechnologies for Gene Therapy"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-93333-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T21:05:12Z","timestamp":1668373512000},"score":25.466398,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-93333-3_5"}},"issued":{"date-parts":[[2022]]},"ISBN":["9783030933326","9783030933333"],"references-count":260,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-93333-3_5","published":{"date-parts":[[2022]]},"assertion":[{"value":"3 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:18:52Z","timestamp":1648775932259},"reference-count":0,"publisher":"Marwah Infotech","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["APJHS"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.21276\/apjhs.2019.6.2.26","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T07:56:22Z","timestamp":1588406182000},"page":"182-183","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR Gene Therapy in Dentistry"],"prefix":"10.21276","volume":"6","author":[{"given":"Anjana","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Doomra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayushi","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kruthiventi","family":"Hemalata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8862","published-online":{"date-parts":[[2019,6]]},"container-title":["Asian Pacific Journal of Health Sciences"],"original-title":["CRISPR Gene Therapy in Dentistry"],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T10:47:13Z","timestamp":1594032433000},"score":24.965464,"resource":{"primary":{"URL":"http:\/\/www.apjhs.com\/index.php\/apjhs\/article\/view\/734\/626"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]},"published-print":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.21276\/apjhs.2019.6.2.26","ISSN":["2350-0964","2349-0659"],"issn-type":[{"value":"2350-0964","type":"print"},{"value":"2349-0659","type":"electronic"}],"published":{"date-parts":[[2019,6]]}},{"institution":[{"name":"Northeastern University"}],"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:27:36Z","timestamp":1648970856727},"reference-count":0,"publisher":"Northeastern University Library","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.17760\/d20356168","type":"dissertation","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:03:36Z","timestamp":1599077016000},"approved":{"date-parts":[[2020]]},"source":"Crossref","is-referenced-by-count":0,"title":["Nanoparticle delivery of CRISPR\/Cas9 gene therapy for Wilson's disease"],"prefix":"10.17760","author":[{"sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7402","deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:03:36Z","timestamp":1599077016000},"score":24.722649,"resource":{"primary":{"URL":"http:\/\/hdl.handle.net\/2047\/D20356168"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.17760\/d20356168"},{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:31:32Z","timestamp":1771979492865,"version":"3.50.1"},"publisher-location":"Cham","reference-count":60,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030933326","type":"print"},{"value":"9783030933333","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-93333-3_4","type":"book-chapter","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:02:50Z","timestamp":1654178570000},"page":"61-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Muscular Dystrophy Therapy Using Viral Vector-based CRISPR\/Cas"],"prefix":"10.1007","author":[{"given":"Eunyoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeyoung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.nmd.2007.07.005","volume":"17","author":"M Neri","year":"2007","unstructured":"Neri, M., Torelli, S., Brown, S., Ugo, I., Sabatelli, P., Merlini, L., Spitali, P., Rimessi, P., Gualandi, F., Sewry, C., Ferlini, A., & Muntoni, F. (2007). Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. Neuromuscular Disorders, 17, 913\u2013918. https:\/\/doi.org\/10.1016\/j.nmd.2007.07.005","journal-title":"Neuromuscular Disorders"},{"key":"4_CR2","first-page":"54","volume":"49","author":"AH Beggs","year":"1991","unstructured":"Beggs, A. H., Hoffman, E. P., Snyder, J. R., Arahata, K., Specht, L., Shapiro, F., Angelini, C., Sugita, H., & Kunkel, L. M. (1991). Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies. American Journal of Human Genetics, 49, 54\u201367.","journal-title":"American Journal of Human Genetics"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S97635","volume":"11","author":"KRQ Lim","year":"2017","unstructured":"Lim, K. R. Q., Maruyama, R., & Yokota, T. (2017). Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Design, Development and Therapy, 11, 533\u2013545. https:\/\/doi.org\/10.2147\/DDDT.S97635","journal-title":"Drug Design, Development and Therapy"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","volume":"80","author":"YA Heo","year":"2020","unstructured":"Heo, Y. A. (2020). Golodirsen: First approval. Drugs, 80, 329\u2013333. https:\/\/doi.org\/10.1007\/s40265-020-01267-2","journal-title":"Drugs"},{"key":"4_CR59","doi-asserted-by":"crossref","unstructured":"Roshmi, R. R., & Yokota, T. (2021). Pharmacological Profile of viltolarsen for the treatment of duchenne muscular dystrophy: A Japanese experience. Clinical Pharmacology: Advances and Applications, 13, 235\u2013242. https:\/\/doi.org\/10.2147\/CPAA.S288842","DOI":"10.2147\/CPAA.S288842"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/nejmoa1000228","volume":"363","author":"JR Mendell","year":"2010","unstructured":"Mendell, J. R., Campbell, K., Rodino-Klapac, L., Sahenk, Z., Shilling, C., Lewis, S., Bowles, D., Gray, S., Li, C., Galloway, G., Malik, V., Coley, B., Clark, K. R., Li, J., Xiao, X., Samulski, J., McPhee, S. W., Samulski, R. J., & Walker, C. M. (2010). Dystrophin immunity in Duchenne\u2019s muscular dystrophy. The New England Journal of Medicine, 363, 1429\u20131437. https:\/\/doi.org\/10.1056\/nejmoa1000228","journal-title":"The New England Journal of Medicine"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996). Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proceedings of the National Academy of Sciences of the United States of America, 93, 1156\u20131160. https:\/\/doi.org\/10.1073\/pnas.93.3.1156","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"4_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl720","volume":"34","author":"J Smith","year":"2006","unstructured":"Smith, J., Grizot, S., Arnould, S., Duclert, A., Epinat, J. C., Chames, P., Prieto, J., Redondo, P., Blanco, F. J., Bravo, J., Montoya, G., P\u00e2ques, F., & Duchateau, P. (2006). A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Research, 34, e149. https:\/\/doi.org\/10.1093\/nar\/gkl720","journal-title":"Nucleic Acids Research"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009). Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 326, 1509\u20131512. https:\/\/doi.org\/10.1126\/science.1178811","journal-title":"Science"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816\u2013821. https:\/\/doi.org\/10.1126\/science.1225829","journal-title":"Science"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., Van Der Oost, J., Regev, A., Koonin, E. V., & Zhang, F. (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163, 759\u2013771. https:\/\/doi.org\/10.1016\/j.cell.2015.09.038","journal-title":"Cell"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., Koonin, E. V., Sharp, P. A., & Zhang, F. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature, 520, 186\u2013191. https:\/\/doi.org\/10.1038\/nature14299","journal-title":"Nature"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"14500","DOI":"10.1038\/ncomms14500","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H. Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., Kim, J. H., Kim, J. H., & Kim, J. S. (2017). In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nature Communications, 8, 14500. https:\/\/doi.org\/10.1038\/ncomms14500","journal-title":"Nature Communications"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533, 420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017). Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature, 551, 464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","volume":"39","author":"IC Kurt","year":"2021","unstructured":"Kurt, I. C., Zhou, R., Iyer, S., Garcia, S. P., Miller, B. R., Langner, L. M., Gr\u00fcnewald, J., & Joung, J. K. (2021). CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nature Biotechnology, 39, 41\u201346. https:\/\/doi.org\/10.1038\/s41587-020-0609-x","journal-title":"Nature Biotechnology"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., & Liu, D. R. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576, 149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4","journal-title":"Nature"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","volume":"87","author":"R Kole","year":"2015","unstructured":"Kole, R., & Krieg, A. M. (2015). Exon skipping therapy for Duchenne muscular dystrophy. Advanced Drug Delivery Reviews, 87, 104\u2013107. https:\/\/doi.org\/10.1016\/j.addr.2015.05.008","journal-title":"Advanced Drug Delivery Reviews"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","volume":"5","author":"YL Min","year":"2019","unstructured":"Min, Y. L., Li, H., Rodriguez-Caycedo, C., Mireault, A. A., Huang, J., Shelton, J. M., McAnally, J. R., Amoasii, L., Mammen, P. P. A., Bassel-Duby, R., & Olson, E. N. (2019). CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci Adv, 5, eaav4324. https:\/\/doi.org\/10.1126\/sciadv.aav4324","journal-title":"Sci Adv"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","volume":"9","author":"L Amoasii","year":"2017","unstructured":"Amoasii, L., Long, C., Li, H., Mireault, A. A., Shelton, J. M., Sanchez-Ortiz, E., McAnally, J. R., Bhattacharyya, S., Schmidt, F., Grimm, D., Hauschka, S. D., Bassel-Duby, R., & Olson, E. N. (2017). Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Sci Transl Med, 9, eaan8081. https:\/\/doi.org\/10.1126\/scitranslmed.aan8081","journal-title":"Sci Transl Med"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","volume":"362","author":"L Amoasii","year":"2018","unstructured":"Amoasii, L., Hildyard, J. C. W., Li, H., Sanchez-Ortiz, E., Mireault, A., Caballero, D., Harron, R., Stathopoulou, T. R., Massey, C., Shelton, J. M., Bassel-Duby, R., Piercy, R. J., & Olson, E. N. (2018). Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science, 362, 86\u201391. https:\/\/doi.org\/10.1126\/science.aau1549","journal-title":"Science"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","volume":"171","author":"HK Liao","year":"2017","unstructured":"Liao, H. K., Hatanaka, F., Araoka, T., Reddy, P., Wu, M. Z., Sui, Y., Yamauchi, T., Sakurai, M., O\u2019Keefe, D. D., N\u00fa\u00f1ez-Delicado, E., Guillen, P., Campistol, J. M., Wu, C. J., Lu, L. F., Esteban, C. R., & Izpisua Belmonte, J. C. (2017). In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell, 171, 1495\u20131507. https:\/\/doi.org\/10.1016\/j.cell.2017.10.025","journal-title":"Cell"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mt.2015.200","volume":"24","author":"CL Himeda","year":"2016","unstructured":"Himeda, C. L., Jones, T. I., & Jones, P. L. (2016). CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy. Molecular Therapy, 24, 527\u2013535. https:\/\/doi.org\/10.1038\/mt.2015.200","journal-title":"Molecular Therapy"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E., Wu, Y., Gemberling, M. P., Oliver, M. L., Waller, M. A., Bohning, J. D., Robinson-Hamm, J. N., Bulaklak, K., Castellanos Rivera, R. M., Collier, J. H., Asokan, A., & Gersbach, C. A. (2019). Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nature Medicine, 25, 427\u2013432. https:\/\/doi.org\/10.1038\/s41591-019-0344-3","journal-title":"Nature Medicine"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ymthe.2019.05.001","volume":"27","author":"L Xu","year":"2019","unstructured":"Xu, L., Lau, Y. S., Gao, Y., Li, H., & Han, R. (2019). Life-long AAV-mediated CRISPR genome editing in dystrophic heart Improves cardiomyopathy without causing serious lesions in mdx mice. Molecular Therapy, 27, 1407\u20131414. https:\/\/doi.org\/10.1016\/j.ymthe.2019.05.001","journal-title":"Molecular Therapy"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008). Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection. Molecular Therapy, 16, 1073\u20131080. https:\/\/doi.org\/10.1038\/mt.2008.76","journal-title":"Molecular Therapy"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","volume":"26","author":"T Koo","year":"2018","unstructured":"Koo, T., Lu-Nguyen, N. B., Malerba, A., Kim, E., Kim, D., Cappellari, O., Cho, H. Y., Dickson, G., Popplewell, L., & Kim, J. S. (2018). Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9. Molecular Therapy, 26, 1529\u20131538. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.018","journal-title":"Molecular Therapy"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., Cong, L., Zhang, F., Vandenberghe, L. H., Church, G. M., & Wagers, A. J. (2016). In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science, 351, 407\u2013411. https:\/\/doi.org\/10.1126\/science.aad5177","journal-title":"Science"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016). Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science, 351, 400\u2013403. https:\/\/doi.org\/10.1126\/science.aad5725","journal-title":"Science"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"SM Ryu","year":"2018","unstructured":"Ryu, S. M., Koo, T., Kim, K., Lim, K., Baek, G., Kim, S. T., Kim, H. S., Kim, D. E., Lee, H., Chung, E., & Kim, J. S. (2018). Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nature Biotechnology, 36, 536\u2013539. https:\/\/doi.org\/10.1038\/nbt.4148","journal-title":"Nature Biotechnology"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1074\/jbc.R113.540310","volume":"289","author":"KV Mills","year":"2014","unstructured":"Mills, K. V., Johnson, M. A., & Perler, F. B. (2014). Protein splicing: How inteins escape from precursor proteins. The Journal of Biological Chemistry, 289, 14498\u201314505. https:\/\/doi.org\/10.1074\/jbc.R113.540310","journal-title":"The Journal of Biological Chemistry"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti, A., Fonteyne, L., Giesert, F., Hoppmann, P., Meier, A. B., Bozoglu, T., et al. (2020). Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nature Medicine, 26, 207\u2013214. https:\/\/doi.org\/10.1038\/s41591-019-0738-2","journal-title":"Nature Medicine"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1038\/srep05105","volume":"4","author":"I Maggio","year":"2014","unstructured":"Maggio, I., Holkers, M., Liu, J., Janssen, J. M., Chen, X., & Gon\u00e7alves, M. A. F. V. (2014). Adenoviral vector delivery of RNA-guided CRISPR\/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Scientific Reports, 4, 5105. https:\/\/doi.org\/10.1038\/srep05105","journal-title":"Scientific Reports"},{"issue":"S164","key":"4_CR33","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1002\/jgm.496","volume":"6","author":"C Volpers","year":"2004","unstructured":"Volpers, C., & Kochanek, S. (2004). Adenoviral vectors for gene transfer and therapy. The Journal of Gene Medicine, 6(S164), S171. https:\/\/doi.org\/10.1002\/jgm.496","journal-title":"The Journal of Gene Medicine"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley, J. L., de Jong, Y. P., Terhorst, C., & Herzog, R. W. (2020). Immune responses to viral gene therapy vectors. Molecular Therapy, 28, 709\u2013722. https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.001","journal-title":"Molecular Therapy"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/mt.2015.192","volume":"24","author":"L Xu","year":"2016","unstructured":"Xu, L., Park, K. H., Zhao, L., Xu, J., El Refaey, M., Gao, Y., Zhu, H., Ma, J., & Han, R. (2016). CRISPR-mediated genome editing restores dystrophin expression and function in mdx mice. Molecular Therapy, 24, 564\u2013569. https:\/\/doi.org\/10.1038\/mt.2015.192","journal-title":"Molecular Therapy"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"37051","DOI":"10.1038\/srep37051","volume":"6","author":"I Maggio","year":"2016","unstructured":"Maggio, I., Liu, J., Janssen, J. M., Chen, X., & Gon\u00e7alves, M. A. F. V. (2016). Adenoviral vectors encoding CRISPR\/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells. Scientific Reports, 6, 37051. https:\/\/doi.org\/10.1038\/srep37051","journal-title":"Scientific Reports"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","volume":"44","author":"I Maggio","year":"2016","unstructured":"Maggio, I., Stefanucci, L., Janssen, J. M., Liu, J., Chen, X., Mouly, V., & Gon\u00e7alves, M. A. F. V. (2016). Selection-free gene repair after adenoviral vector transduction of designer nucleases: Rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Research, 44, 1449\u20131470. https:\/\/doi.org\/10.1093\/nar\/gkv1540","journal-title":"Nucleic Acids Research"},{"key":"4_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv031","volume":"43","author":"M M\u00fcck-H\u00e4usl","year":"2015","unstructured":"M\u00fcck-H\u00e4usl, M., Solanki, M., Zhang, W., Ruzsics, Z., & Ehrhardt, A. (2015). Ad 2.0: A novel recombineering platform for high-throughput generation of tailored adenoviruses. Nucleic Acids Res, 43, e50. https:\/\/doi.org\/10.1093\/nar\/gkv031","journal-title":"Nucleic Acids Res"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"17113","DOI":"10.1038\/s41598-017-17180-w","volume":"7","author":"E Ehrke-Schulz","year":"2017","unstructured":"Ehrke-Schulz, E., Schiwon, M., Leitner, T., D\u00e1vid, S., Bergmann, T., Liu, J., & Ehrhardt, A. (2017). CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes. Scientific Reports, 7, 17113. https:\/\/doi.org\/10.1038\/s41598-017-17180-w","journal-title":"Scientific Reports"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","volume":"99","author":"A Ehrhardt","year":"2002","unstructured":"Ehrhardt, A., & Kay, M. A. (2002). A new aadnoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. Blood, 99, 3923\u20133930. https:\/\/doi.org\/10.1182\/blood.V99.11.3923","journal-title":"Blood"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/cells9040869","volume":"9","author":"M Brescia","year":"2020","unstructured":"Brescia, M., Janssen, J. M., Liu, J., & Gon\u00e7alves, M. A. F. V. (2020). High-capacity adenoviral vectors permit robust and versatile testing of DMD gene repair tools and strategies in human cells. Cell, 9, 869. https:\/\/doi.org\/10.3390\/cells9040869","journal-title":"Cell"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/156652308786848012","volume":"8","author":"C Sarkis","year":"2008","unstructured":"Sarkis, C., Philippe, S., Mallet, J., & Serguera, C. (2008). Non-integrating lentiviral vectors. Current Gene Therapy, 8, 430\u2013437. https:\/\/doi.org\/10.2174\/156652308786848012","journal-title":"Current Gene Therapy"},{"key":"4_CR43","doi-asserted-by":"publisher","DOI":"10.3791\/59432","volume":"151","author":"Y Jin","year":"2019","unstructured":"Jin, Y., Shen, Y., Su, X., Weintraub, N., & Tang, Y. (2019). CRISPR\/Cas9 technology in restoring dystrophin expression in iPSC-derived muscle progenitors. Journal of Visualized Experiments, 151, e59432. https:\/\/doi.org\/10.3791\/59432","journal-title":"Journal of Visualized Experiments"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","volume":"26","author":"BL Duch\u00eane","year":"2018","unstructured":"Duch\u00eane, B. L., Cherif, K., Iyombe-Engembe, J. P., Guyon, A., Rousseau, J., Ouellet, D. L., Barbeau, X., Lague, P., & Tremblay, J. P. (2018). CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo. Molecular Therapy, 26, 2604\u20132616. https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.010","journal-title":"Molecular Therapy"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","volume":"7","author":"A Lattanzi","year":"2017","unstructured":"Lattanzi, A., Moiani, A., Izmiryan, A., Martin, S., Mavilio, F., Bovolenta, M., Duguez, S., Mamchaoui, K., Mouly, V., Barbon, E., & Bernardi, F. (2017). Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR\/Cas9 system. Molecular Therapy Nucleic Acids, 7, 11\u201319. https:\/\/doi.org\/10.1016\/j.omtn.2017.02.004","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajhg.2015.11.012","volume":"98","author":"D Wojtal","year":"2016","unstructured":"Wojtal, D., Kemaladewi, D. U., Malam, Z., Abdullah, S., Wong, T. W. Y., Hyatt, E., Baghestani, Z., Pereira, S., Stavropoulos, J., Mouly, V., Mamchaoui, K., Muntoni, F., Voit, T., Gonorazky, H. D., Dowling, J. J., Wilson, M. D., Mendoza-Londono, R., Ivakine, E. A., & Cohn, R. D. (2016). Spell checking nature: Versatility of CRISPR\/Cas9 for developing treatments for inherited disorders. American Journal of Human Genetics, 98, 90\u2013101. https:\/\/doi.org\/10.1016\/j.ajhg.2015.11.012","journal-title":"American Journal of Human Genetics"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.aav9023","volume":"364","author":"B Wienert","year":"2019","unstructured":"Wienert, B., Wyman, S. K., Richardson, C. D., Yeh, C. D., Akcakaya, P., Porritt, M. J., Morlock, M., Vu, J. T., Kazane, K. R., Watry, H. L., Judge, L. M., Conklin, B. R., Maresca, M., & Corn, J. E. (2019). Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. Science, 364, 286\u2013289. https:\/\/doi.org\/10.1126\/science.aav9023","journal-title":"Science"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ymthe.2018.10.009","volume":"27","author":"DH Jo","year":"2019","unstructured":"Jo, D. H., Koo, T., Cho, C. S., Kim, J. H., Kim, J. S., & Kim, J. H. (2019). Long-term effects of in vivo genome editing in the mouse retina using Campylobacter jejuni Cas9 expressed via adeno-associated virus. Molecular Therapy, 27, 130\u2013136. https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.009","journal-title":"Molecular Therapy"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/crispr.2019.0006","volume":"2","author":"E Rayner","year":"2019","unstructured":"Rayner, E., Durin, M.-A., Thomas, R., Moralli, D., O\u2019Cathail, S. M., Tomlinson, I., Green, C. M., & Lewis, A. (2019). CRISPR-Cas9 causes chromosomal instability and rearrangements in cancer cell lines, detectable by cytogenetic methods. CRISPR Journal, 2, 406\u2013416. https:\/\/doi.org\/10.1089\/crispr.2019.0006","journal-title":"CRISPR Journal"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"14370","DOI":"10.1038\/ncomms14370","volume":"8","author":"S Senturk","year":"2017","unstructured":"Senturk, S., Shirole, N. H., Nowak, D. G., Corbo, V., Pal, D., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kinney, J. B., & Sordella, R. (2017). Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization. Nature Communications, 8, 14370. https:\/\/doi.org\/10.1038\/ncomms14370","journal-title":"Nature Communications"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nbt.3155","volume":"33","author":"LE Dow","year":"2015","unstructured":"Dow, L. E., Fisher, J., O\u2019Rourke, K. P., Muley, A., Kastenhuber, E. R., Livshits, G., Tschaharganeh, D. F., Socci, N. D., & Lowe, S. W. (2015). Inducible in vivo genome editing with CRISPR-Cas9. Nature Biotechnology, 33, 390\u2013394. https:\/\/doi.org\/10.1038\/nbt.3155","journal-title":"Nature Biotechnology"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.cell.2017.07.037","volume":"170","author":"LB Harrington","year":"2017","unstructured":"Harrington, L. B., Doxzen, K. W., Ma, E., Liu, J. J., Knott, G. J., Edraki, A., Garcia, B., Amrani, N., Chen, J. S., Cofsky, J. C., Kranzusch, P. J., Sontheimer, E. J., Davidson, A. R., Maxwell, K. L., & Doudna, J. A. (2017). A broad-spectrum inhibitor of CRISPR-Cas9. Cell, 170, 1224\u20131233. https:\/\/doi.org\/10.1016\/j.cell.2017.07.037","journal-title":"Cell"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A., Lee, C. M., Hurley, A. E., Jarrett, K. E., De Giorgi, M., Lu, W., Balderrama, K. S., Doerfler, A. M., Deshmukh, H., Ray, A., Bao, G., & Lagor, W. R. (2019). A self-deleting AAV-CRISPR system for in vivo genome editing. Molecular Therapy \u2013 Methods and Clinical Development, 12, 111\u2013122. https:\/\/doi.org\/10.1016\/j.omtm.2018.11.009","journal-title":"Molecular Therapy \u2013 Methods and Clinical Development"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin, H., Song, C. Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., et al. (2016). Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nature Biotechnology, 34, 328\u2013333. https:\/\/doi.org\/10.1038\/nbt.3471","journal-title":"Nature Biotechnology"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtm.2019.12.008","volume":"17","author":"AT Martino","year":"2020","unstructured":"Martino, A. T., & Markusic, D. M. (2020). Immune response mechanisms against AAV vectors in animal models. Molecular Therapy \u2013 Methods and Clinical Development, 17, 198\u2013208. https:\/\/doi.org\/10.1016\/j.omtm.2019.12.008","journal-title":"Molecular Therapy \u2013 Methods and Clinical Development"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim, S., Koo, T., Jee, H. G., Cho, H. Y., Lee, G., Lim, D. G., Shin, H. S., & Kim, J. S. (2018). CRISPR RNAs trigger innate immune responses in human cells. Genome Research, 28, 367\u2013373. https:\/\/doi.org\/10.1101\/gr.231936.117","journal-title":"Genome Research"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T., Deshpande, P. S., Dever, D. P., Camarena, J., Lemgart, V. T., Cromer, M. K., Vakulskas, C. A., Collingwood, M. A., Zhang, L., Bode, N. M., Behlke, M. A., Dejene, B., Cieniewicz, B., Romano, R., Lesch, B. J., Gomez-Ospina, N., Mantri, S., Pavel-Dinu, M., Weinberg, K. I., & Porteus, M. H. (2019). Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nature Medicine, 25, 249\u2013254. https:\/\/doi.org\/10.1038\/s41591-018-0326-x","journal-title":"Nature Medicine"},{"key":"4_CR61","doi-asserted-by":"crossref","unstructured":"Ferdosi, S. R., Ewaisha, R., Moghadam, F., Krishna, S., Park, J. G., Ebrahimkhani, M. R., Kiani, S., Anderson, K. S. (2019) Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nature Communications 10(1), https:\/\/doi.org\/10.1038\/s41467-019-09693-x","DOI":"10.1038\/s41467-019-09693-x"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L., Amini, L., Wendering, D. J., Burkhardt, L. M., Aky\u00fcz, L., Reinke, P., Volk, H. D., & Schmueck-Henneresse, M. (2019). High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nature Medicine, 25, 242\u2013248. https:\/\/doi.org\/10.1038\/s41591-018-0204-6","journal-title":"Nature Medicine"}],"container-title":["Biotechnologies for Gene Therapy"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-93333-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:20:50Z","timestamp":1654179650000},"score":24.237925,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-93333-3_4"}},"issued":{"date-parts":[[2022]]},"ISBN":["9783030933326","9783030933333"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-93333-3_4","published":{"date-parts":[[2022]]},"assertion":[{"value":"3 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}],"items-per-page":5,"query":{"start-index":0,"search-terms":"CRISPR gene therapy"}}}